ZIF-8 Nanodelivery Systems: Construction Strategies, Functional Modifi

Introduction

Malignant tumors severely endanger human well being and symbolize a significant public well being situation. Medical therapy methods have developed from standard chemotherapy and radiotherapy to different modalities akin to phototherapy and immunotherapy.^1,2 Nonetheless, every monotherapy has inherent limitations chemotherapeutic brokers lack tumor specificity, resulting in extreme systemic toxicity; radiotherapy tends to trigger regular tissue injury and radiation resistance; phototherapy is restricted by tissue penetration depth; and immunotherapy faces low response charges and immune-related antagonistic occasions. The advanced tumor microenvironment (TME), characterised by low pH, excessive glutathione (GSH) focus, hypoxia, and dense stromal obstacles, severely hinders intratumoral drug supply and penetration whereas inducing multidrug resistance (MDR), considerably lowering the bioavailability of standard chemotherapeutic medicine.^3,4 Due to this fact, there may be an pressing must develop clever drug supply methods that includes energetic tumor focusing on, microenvironment-responsive launch, and low unwanted side effects.

Nanodrug supply methods (NDDS) encapsulate therapeutic brokers inside nanoscale carriers.⁵ NDDS can obtain passive tumor focusing on through the improved permeability and retention (EPR) impact or energetic focusing on by floor modification with focusing on ligands.^6,7 NDDS considerably enhance the circulation stability of medicine, scale back uptake by regular tissues, and allow managed or stimuli-responsive launch, thereby enhancing therapeutic efficacy whereas minimizing toxicity.^5,8 In contrast with standard formulations, nanocarriers have turn out to be an essential path within the discipline of most cancers remedy.

Metallic-organic frameworks (MOFs) are porous hybrid supplies self-assembled from metallic ions or clusters, which coordinate into two- or three-dimensional community crystal buildings.^9,10 MOFs possess ultrahigh porosity and intensely giant floor areas, exceeding 6000 m²/g.¹¹ In contrast with conventional drug carriers akin to liposomes and polymeric nanoparticles, MOFs exhibit superior drug loading capability.¹² As nanocarriers, MOFs supply distinctive benefits together with pH responsiveness, tunable pore sizes, excessive effectivity, low toxicity, and lack of unwanted side effects.^13,14 The managed host–visitor interactions and biodegradability achieved by coordination strategies additional improve the attractiveness of MOFs for drug supply functions.¹⁵

ZIF-8, an essential subclass of the MOF household and some of the consultant ZIF sorts, is self-assembled by coordinating Zn²⁺ with 2-methylimidazole (2-Meim) and may passively goal diseased tissues through the EPR impact.¹⁶ ZIF-8 displays good biocompatibility: Zn²⁺ is a vital hint ingredient for the human physique, and 2-Meim reveals good organic tolerance, enabling gradual degradation and metabolic elimination in physiological environments.¹⁷ Research have demonstrated that ZIF-8 is pH-responsive: beneath regular physiological situations (pH 7.4), the ZIF-8 construction stays steady, whereas within the acidic tumor microenvironment (pH 5.0–6.5), the Zn²⁺-imidazolate coordination bonds bear protonation-induced cleavage, resulting in framework disintegration and managed launch of the encapsulated cargo, thereby reaching exact “lysosomal/tumor acidity-triggered” supply (Figure 1).¹⁸ Moreover, owing to its excessive particular floor space and ample interactions akin to π-π stacking and hydrogen bonding, ZIF-8 displays glorious loading effectivity for a variety of chemotherapeutic brokers, photosensitizers, and genetic medicine.¹⁹ The synthesis of ZIF-8 is gentle and facile: it may be quickly synthesized in aqueous or methanol phases at room temperature, and its imidazole-rich floor facilitates covalent or bodily modifications, additional endowing it with “stealth” and “navigation” capabilities, which symbolize basic approaches to reaching environment friendly and low-toxicity antitumor remedy. In contrast with conventional nanocarriers akin to liposomes, polymer nanoparticles, and mesoporous silica, liposomes and polymer methods typically exhibit sudden launch, whereas mesoporous silica requires advanced floor functionalization to realize stimulus responsiveness. In distinction, ZIF-8 affords vital benefits: it quickly disintegrates beneath acidic situations, making it extra appropriate for tumor microenvironment-responsive drug supply—a property that conventional carriers lack or can obtain solely by advanced coating processes. Moreover, its gentle aqueous synthesis course of and ample imidazole teams facilitate handy post-modification with PEG, focusing on ligands, or biomimetic membranes, offering a multifunctional platform for energetic tumor-targeted supply and managed launch. Nonetheless, this pH responsiveness additionally poses stability challenges inside endosomes, doubtlessly resulting in untimely drug launch throughout mobile uptake-a trade-off that should be fastidiously weighed in formulation design. In comparison with different MOFs, such because the MIL and UiO sequence, ZIF-8 avoids the usage of extremely poisonous heavy metals (akin to chromium or zirconium precursors) and displays distinctive stability. This makes it some of the promising MOF carriers for in vivo supply functions.²⁰ Though earlier opinions have summarized the applying of MOFs in drug supply, a scientific efficiency comparability of ZIF-8 and the rationale behind its use in multimodal synergistic remedy stay insufficiently addressed. This evaluate systematically presents current advances in ZIF-8 nanoparticles (ZIF-8 NPs) for most cancers remedy. First, we summarize the preparation strategies of ZIF-8 and its modifications for most cancers remedy. Subsequently, we evaluate and focus on the functions of ZIF-8 nanomaterials in most cancers therapy, together with potential shortcomings or challenges. On the idea of this evaluate, we purpose to maximise the potential of ZIF-8 nanomaterials.

Determine 1 The core paradigm of the ZIF-8 nanoplatform for tumor remedy. (A) Synthesis, drug co-loading, and floor functionalization modification of ZIF-8; (B) Structural modifications and launch mechanisms of ZIF-8 beneath totally different pH situations; (C) Functions of ZIF-8 in nanomedicine supply methods. (The determine was created in https://BioRender.com).

ZIF-8 Synthesis Methodology

Room Temperature Stirring Methodology

Includes mixing options of, for instance, zinc nitrate (Zn(NO₃)₂·6H₂O) and 2-methylimidazole (2-Hmim) in methanol or water at room temperature, permitting speedy coordination-driven self-assembly to type ZIF-8 nanoparticles. That is the only and mostly used laboratory preparation methodology. Missaoui employed dimethylformamide (DMF) because the solvent beneath room-temperature situations with stirring for roughly 1 hour to acquire hexagonal ZIF-8 nanoparticles with a mean particle measurement of 150 nm.21 Zheng et al encapsulated the anticancer drug doxorubicin (DOX) into ZIF-8 for the therapy of breast most cancers (BC). They dissolved 0.2 g of Zn(NO₃)₂·6H₂O in 0.8 g of H₂O and added 4 mL of DOX inventory answer to the zinc nitrate answer. After stirring for 1 min, an answer containing 2 g of 2-Hmim and eight g of deionized water (complete 10 g) was added dropwise. The response combination was stirred for 15 min, reaching a DOX loading capability of as much as 20%.²² Though this methodology is extremely appropriate for speedy screening of drug loading situations and preliminary in vitro efficacy analysis, its major limitation lies within the often-overlooked batch-to-batch variations in particle measurement and measurement distribution. Such polydispersity can profoundly have an effect on EPR-dependent tumor accumulation, resulting in poor in vivo–in vitro correlation.

Solvothermal Methodology

Includes dissolving Zn(NO₃)₂·6H₂O and 2-Hmim in natural solvents akin to methanol or DMF, adopted by response in a sealed autoclave at elevated temperature (80–150°C) and strain for a number of to tens of hours, throughout which coordination-driven self-assembly yields ZIF-8 crystals. Yang et al dissolved Zn(NO₃)₂·6H₂O in a beaker containing a methanol answer and 2-Hmim in one other beaker. Subsequently, the zinc salt answer was poured into the beaker containing 2-Hmim, stirred for 30 min, ultrasonicated for five min, after which heated in a 70°C water bathtub for 20 min to acquire ZIF-8.²³ Almutairy et al used this methodology to synthesize radiolabeled ZIF-8 with a particle measurement of 198 ± 9.8 nm, a polydispersity index (PDI) of 0.219 ± 0.011, and a hemolysis price beneath 5%, indicating good dispersibility and biocompatibility.²⁴ Gao first blended Zn(NO₃)₂·6H₂O and 2-Hmim in methanol, subjected the combination to room-temperature ultrasonication to acquire preliminary ZIF-8 nanoparticles, then supplemented the response with a further zinc supply, transferred the combination to a Teflon-lined autoclave, and carried out a hydrothermal response at 120°C for two h. After washing and drying, ZIF-8 with increased crystallinity was obtained.²⁵ This methodology produces ZIF-8 with excessive crystallinity and common morphology, making it appropriate for basic structural characterization and mechanistic research. Nonetheless, the excessive strain, excessive temperature, and extended response situations not solely eat substantial power but in addition are troublesome to scale up. Furthermore, this methodology is unsuitable for loading heat-labile biomacromolecules, and the excessive strain hinders real-time monitoring of the encapsulation course of.

Ultrasound and Microwave-Assisted Methodology

The ultrasound and microwave-assisted methodology makes use of the speedy and uniform heating of polar molecules (eg, water, methanol) by microwave irradiation to enormously speed up the nucleation and crystal progress of ZIF-8. Bazzi et al investigated the conversion of zinc oxide (ZnO) to ZIF-8 in numerous solvent mixtures utilizing ultrasound and microwave help (Figure 2), demonstrating that the microwave methodology can synthesize size-tunable ZIF-8 inside minutes (solely 40 minutes) with a yield of 92% and glorious adsorption capability.²⁶ Yao et al employed a stepwise ultrasound-assisted methodology to synthesize ZIF-8 and studied the regulatory impact of ultrasound on the morphology of ZIF-8. First, 3.75 mmol of Zn(NO₃)₂·6H₂O and seven.5 mmol of 2-Hmim had been dissolved in methanol. Below ultrasonic agitation, half of the zinc salt answer was slowly injected into the methanol answer and reacted for two min, adopted by injection of the remaining half and continued ultrasonication for 10 min to permit full response, yielding a milky white suspension of ZIF-8.²⁷ This methodology options extraordinarily quick response charges, uniform heating, excessive crystallinity, and good controllability over morphology and measurement, making it appropriate for preliminary research requiring speedy preparation or measurement screening. Nonetheless, it additionally suffers from excessive gear prices and usually small response volumes.

Determine 2 Schematic of ultrasound and microwave-assisted synthesis of ZIF-8. Reproduced from.²⁶ Licensed beneath CC BY.

Microfluidic Steady Synthesis Methodology

Microfluidic know-how, owing to its capacity to realize steady manufacturing, glorious batch-to-batch reproducibility, and exact management over particle measurement, is taken into account one of many key applied sciences for the medical translation and large-scale manufacturing of ZIF-8 nanoparticles. As proven in Figure 3, Gao et al employed microfluidic know-how to arrange core-shell structured CUR@ZIF-8-SF-PDA nanoparticles for breast most cancers remedy, reaching functionalization by simultaneous loading of curcumin (CUR), silk fibroin, and polydopamine (PDA). This methodology enabled exact management over the proportions of every part, yielding nanoparticles with a measurement of roughly 170 nm.²⁸ In contrast with the normal magnetic stirring methodology, the microfluidic technique considerably improved the dimensions uniformity and dispersibility of the nanoparticles. Shen et al used a microfluidic continuous-flow mixing chip to realize exact manipulation of three-phase circulation, and the ready core-shell nanoparticles had been superior to these obtained by conventional mixing strategies when it comes to measurement uniformity, structural integrity, and drug loading effectivity.²⁹ Carrao et al utilized the continuous-flow methodology for the primary time to synthesize ZIF-8 biocomposites. Utilizing a easy microfluidic system composed of Y- and T-shaped mixers, they efficiently co-encapsulated bovine serum albumin (BSA) and α1-antitrypsin into ZIF-8, producing size-uniform ZIF-8 particles smaller than 200 nm, assembly the important thing measurement requirement for intravenous drug supply methods.³⁰ Though the nanoparticles ready by the microfluidic methodology exhibit excessive uniformity, low throughput stays a significant bottleneck.

Determine 3 Schematic diagram of microfluidic-assisted preparation of ZIF-8. (A) Schematic diagram of speedy mixing-based preparation. (B) Schematic diagram of a microfluidic methodology for getting ready ZIF-8-based nanoparticles.²⁸

Mechanochemical Synthesis Methodology

The mechanochemical synthesis methodology makes use of mechanical power generated by high-frequency affect and friction from milling balls in gear akin to ball mills to switch the solvent setting and exterior heating required in conventional synthesis, permitting solid-state zinc salts (eg, ZnO) and 2-Hmim to immediately bear coordination reactions to type ZIF-8. This methodology is subsequently additionally thought of a inexperienced synthesis strategy.31 Tanaka et al first confirmed the mechanochemical dry conversion of ZnO to ZIF-8; after 96 h of ball milling, the precise floor space and micropore quantity reached 1480 m² g⁻¹ and 0.55 cc g⁻¹, respectively, with a yield as excessive as 80%.³² Balderas et al synthesized ZIF-8 by mechanochemical twin-screw extrusion at a screw velocity of 150 rpm, reaching a manufacturing price of 1.3 kg/h. The product exhibited steady hydrogen storage efficiency at 77 Okay, with a usable capability of as much as 31.1 g H₂ L⁻¹.³³ Brekalo demonstrated that in a mechanochemical response of fundamental zinc carbonate and 2-Hmim (1:3) floor in a planetary mill, a considerable amount of pure ZIF-8 may very well be shaped at room temperature.³⁴ For software situations requiring large-scale manufacturing however not demanding excessive monodispersity of nanoparticles, this methodology is extremely engaging.

Spray Drying Methodology

Wei et al employed spray drying know-how to assemble hierarchically porous ZIF-8. Utilizing ZIF-8 nanoparticles of various sizes as precursors, they ready aqueous dispersions and accomplished spray drying beneath parameters akin to an inlet air temperature of 373 Okay and a feed price of 15 mL/min. This efficiently achieved environment friendly encapsulation of DOX, with drug loading and encapsulation effectivity as excessive as 79%, considerably enhancing the loading capability and managed launch efficiency of DOX.³⁵ Fan et al innovatively used a sprig deposition methodology to assemble a ZIF-8/polyvinyl alcohol composite separation membrane on a polyvinylidene fluoride fiber substrate. By optimizing the spray course of, the ZIF-8 loading was 20–30 wt%, reaching uniform dispersion of ZIF-8 NPs within the coating and successfully fixing the agglomeration downside frequent in conventional coating strategies.³⁶ Arora et al mixed ultrasound with spray drying know-how. First, beneath ultrasound, an answer containing 2-Hmim was dropped right into a zinc-containing answer to synthesize a milky white ZIF-8 answer, which was then spray-dried to acquire the ultimate piperine-loaded ZIF-8 (PIP@ZIF-8) powder with a yield of 38.3%.³⁷ Spray drying is appropriate for the post-treatment of heat-tolerant medicine or inorganic nanoparticles and for steady, large-scale industrial manufacturing, and it will possibly immediately yield stable powders which might be straightforward to retailer and transport.

Technique for Methodology Choice

For laboratory validation and drug screening, the room-temperature stirring methodology is the primary selection resulting from its simplicity and velocity. Nonetheless, given the batch-to-batch variability, essential experiments ought to be validated with replicates. When extremely uniform particle measurement and batch-to-batch stability are required, the microfluidic methodology is most popular, particularly for research requiring strict in vivo–in vitro correlation or exact focused supply. For loading heat-labile biomacromolecules, the solvothermal and spray drying strategies ought to be averted; the one-pot methodology beneath room-temperature stirring or the microfluidic methodology beneath gentle situations is most popular. For inexperienced chemistry and large-scale industrial manufacturing, mechanochemical synthesis and spray drying are the principle candidates. Primarily based on the above evaluation, the selection of ZIF-8 preparation methodology ought to be weighed towards particular analysis goals. Table 1 summarizes the benefits, disadvantages, and medical translation potential of various preparation strategies.

Desk 1 Benefits and Disadvantages of Completely different Preparation Strategies and Their Medical Translation Potential

Drug Loading Strategies of ZIF-8

The drug loading technique of ZIF-8 immediately impacts the drug loading effectivity, launch habits, and bioactivity. As proven in Figure 4, Present mainstream strategies embody the one-pot methodology (in situ synthesis) and the impregnation methodology (post-loading), along with some hybrid methods akin to “in situ synthesis adopted by loading” and “solvent-assisted loading.” The loading mechanisms, relevant medicine, and launch kinetic traits of various strategies range considerably, requiring rational choice based mostly on drug properties and therapeutic wants.

Determine 4 Schematic diagram of preparation strategies utilizing the one-pot course of and impregnation methodology. (A) One-pot methodology (B) Immersion methodology. (The determine was created in https://BioRender.com).

One-Pot Methodology

The one-pot methodology is a generally used strategy for drug loading into ZIF-8. It’s an modern methodology that concurrently completes ZIF-8 framework synthesis and drug encapsulation in a single response system, avoiding the cumbersome means of first synthesizing after which loading medicine as within the impregnation methodology. On this methodology, drug molecules are encapsulated in situ throughout the pores in the course of the coordination nucleation of Zn²⁺ and 2-Hmim, leading to elevated drug loading and extra uniform nanoparticle measurement, with robust versatility.38,39 Guo et al used the one-pot methodology to co-encapsulate ICG and Cy5.5 into ZIF-8, getting ready dextran-decorated Cy5.5&ICG@ZIF-8-Dex nanoparticles for the therapy of non-small cell lung most cancers. These nanoparticles exhibited glorious tumor-targeting capacity and photothermal therapeutic efficacy, with fluorescence depth 40 instances that of free Cy5.5, owing to the EPR impact.⁴⁰ To reinforce the therapeutic impact of temozolomide (TMZ) on glioma, Ren designed a tannic acid (TA)-modified ZIF-8 nanoparticle loaded with TMZ. This nanoparticle successfully inhibited the migration and invasion of U251 glioma cells and considerably induced apoptosis by regulating ROS/MMP ranges and apoptosis-related protein pathways, demonstrating stronger antitumor exercise than free TMZ.⁴¹ Analysis signifies that this methodology usually achieves excessive drug loading and encapsulation effectivity.⁴² The one-pot methodology is appropriate for small-molecule chemotherapeutic medicine, photosensitizers, and a few biomacromolecules, however consideration ought to be paid to the synthesis situations (eg, pH, solvent) which will have an effect on the exercise of delicate medicine.

Impregnation Methodology

The impregnation methodology (IM) is likely one of the mostly used post-modification or drug loading methods. It usually refers back to the means of loading goal molecules into the pores or onto the exterior floor of pre-synthesized ZIF-8 carriers by bodily adsorption, capillary motion, and van der Waals forces.⁴³ Padya designed a topical gel supply system based mostly on Sonidegib (SDG)-modified ZIF-8. First, modified ZIF-8 was synthesized utilizing the one-pot methodology, adopted by loading of 5-fluorouracil (5-FU) through the impregnation methodology to reinforce penetration by the follicular route. SDG concurrently exerted focusing on and therapeutic results, reaching synergistic enhancement of 5-FU and SDG in basal cell carcinoma.⁴⁴ Mi designed a folate receptor (FR)-targeting ZIF-8 nanoparticle loaded with baicalin (BAN) (PEG-FA@ZIF-8@BAN). BAN was loaded into the pores of FA-ZIF-8 through the impregnation methodology, reaching an encapsulation effectivity of 65.83 ± 3.35%. In contrast with different BAN nanodelivery methods, PEG-FA@ZIF-8@BAN exhibited increased drug loading effectivity.⁴⁵ The impregnation methodology is especially appropriate for medicine delicate to synthesis situations, akin to proteins, peptides, and nucleic acids, in addition to focusing on ligands or practical molecules that require post-modification introduction.

Methodology Comparability

Within the one-pot methodology, medicine are encapsulated throughout the cage-like framework of ZIF-8, leading to robust interactions with the framework. Within the impregnation methodology, medicine are primarily adsorbed onto the exterior floor or pore openings, primarily by bodily adsorption, leading to weaker interactions with the framework.⁴⁶ Concerning launch kinetics, the one-pot methodology achieves long-term sustained launch; drug molecules should slowly diffuse outward by the microporous channels inside ZIF-8, encountering vital steric hindrance and diffusion resistance, resulting in a low and fixed launch price. In distinction, the impregnation methodology achieves speedy launch, with the discharge price primarily restricted by the desorption means of drug molecules from the service floor, involving fewer limiting components and leading to sooner launch. A research evaluating the 2 strategies for Ag(I) ion loading confirmed that one-pot synthesized ZIF-8 exhibited a considerably decrease and extra fixed ion launch price in synthetic seawater, whereas ions adsorbed on the floor through the impregnation methodology had been launched extra rapidly.⁴⁷ For long-term sustained launch and exact focusing on, the one-pot methodology is most popular; for speedy motion or floor functionalization, the impregnation methodology could also be chosen. Though the one-pot methodology usually achieves increased drug-loading effectivity, researchers should assess whether or not encapsulation impacts drug bioactivity. Specifically, for biomacromolecules akin to proteins and nucleic acids, in situ synthesis situations, such because the presence of Zn²⁺ or pH modifications, might result in aggregation or lack of operate. Moreover, the next drug load doesn’t robotically translate to higher therapeutic outcomes; for sure medicine that require speedy attainment of peak concentrations to beat resistance mechanisms, sustained-release may very well be detrimental.

Functionalization Modifications of ZIF-8 Nanocarriers

Biocompatibility Modification

The in vivo software of pristine ZIF-8 is restricted by poor stability, non-specific distribution, and immune clearance. Due to this fact, hierarchical functionalization is required to regularly deal with these points: first enhancing biocompatibility, then conferring energetic focusing on functionality, and eventually reaching biomimetic stealth.

Polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and polydopamine (PDA) are generally used modification supplies in most cancers remedy. Developing a polymer protecting layer on the ZIF-8 floor through bodily adsorption or covalent crosslinking is a common methodology to stability stability and biocompatibility. Research have confirmed that PEG modification can successfully improve the efficiency of ZIF-8. For instance, Peng used PEG-2000 to change ZIF-8 loaded with hinokiflavone (HF), exhibiting glorious biocompatibility (cell viability >99%) and enhancing colloidal stability whereas lowering non-specific adsorption in vivo, which is especially essential for oral administration.⁴⁸ Equally, Zhang et al used FA-PEG to change ZIF-8, successfully stopping nanoparticle aggregation and enhancing their dispersibility with out altering their intrinsic construction.⁴⁹ PDA itself is a superb photothermal agent wealthy in energetic teams akin to catechol and amino teams.^50,51 Zhang et al modified the floor of ZIF-8 with PDA, loaded MF-094, and achieved subsequent functionalization with PEG-thiophosphate, synergistically enhancing the tumor focusing on and mobile uptake effectivity of the service.⁵² Yin mixed chemotherapy and photothermal remedy utilizing PDA-modified methotrexate (MTX)-loaded ZIF-8 NPs, successfully addressing the restrictions of monotherapy, avoiding burst drug launch, and enhancing the biocompatibility and near-infrared (NIR) mild absorption efficiency of the nanoparticles.⁵³

Energetic Focusing on Modification

To reinforce the buildup of ZIF-8 nanomedicines in tumors and scale back their systemic toxicity, energetic focusing on floor modification methods are essential. At the moment, generally used modifications fall into three classes: small molecule focusing on, polysaccharide focusing on, and peptide focusing on. Folic acid (FA) is probably the most generally used small-molecule focusing on ligand. The folate receptor (FR) is a glycosylphosphatidylinositol-anchored membrane glycoprotein primarily current on cell surfaces, exhibiting excessive affinity for FA.⁵⁴ Research have proven that FA-modified ZIF-8 stays structurally steady in impartial environments (pH 7.4) with low drug launch, lowering toxicity to regular tissues. Within the acidic situations of the tumor microenvironment (pH 5.0), the service framework disintegrates, and the drug launch effectivity will increase threefold in contrast with physiological situations, reaching sustained launch of curcumin on the goal web site and enhancing therapeutic efficacy towards cervical most cancers.⁵⁵ Li designed an Fe/ZIF-8 service co-loading glucose oxidase (GOx), L-arginine, and DOX. In vitro and in vivo experiments confirmed that FA modification endows ZIF-8 NPs with glorious tumor focusing on and biocompatibility, enormously rising drug accumulation on the tumor web site and considerably enhancing the synergistic antitumor impact of starvation-like remedy, chemodynamic remedy, nitric oxide fuel remedy, and chemotherapy.⁵⁶

Hyaluronic acid (HA) is a pure polysaccharide that may be metabolized naturally within the human physique. Its distinctive benefit lies in its capacity to actively acknowledge and bind to the CD44 receptor, which is extremely expressed on the floor of tumor cells.^57,58 Track et al mixed the benefits of HA, ZIF-8, and molecularly imprinted polymers (MIPs) for the therapy of prostate most cancers. HA performed a twin function: not solely binding to the CD44 receptor to focus on prostate most cancers cells but in addition being degradable by hyaluronidase (HAase), which is extremely expressed within the tumor microenvironment, reaching twin pH/enzyme responsiveness.⁵⁹ Li used HA to change ZIF-8 co-loading ICG and the glycolysis inhibitor cryptotanshinone (CTS). The HA-coated ZIF-8 enhanced the in vitro and in vivo focusing on capacity of ZIF-8 by each the EPR impact and CD44-mediated energetic tumor focusing on, thereby rising drug focus and conferring glorious focusing on and synergistic therapeutic functionality.⁶⁰

RGD peptides are quick peptide sequences composed of arginine, glycine, and aspartic acid that particularly acknowledge integrin receptors extremely expressed on the floor of most cancers cells.^61,62 Meng designed a nanodelivery system during which metformin (Met) and glucose oxidase (GOx) had been encapsulated in histidine/ZIF-8 (His/ZIF-8) and coated with Arg-Gly-Asp (RGD) peptide (Met/GOx@His/ZIF-8∼RGD). After RGD peptide modification, MDA-MB-231 most cancers cells exhibited higher mobile uptake in contrast with non-RGD-modified NPs.⁶³ Kamal investigated the pH responsiveness of the RGD-functionalized nanocarrier GEM⊂RGD@nZIF-8 and its biosafety in wholesome zebrafish embryos. RGD not solely endowed the nanocarrier with the power to focus on most cancers cells but in addition improved its biocompatibility, with an LC₅₀ > 250 μg mL⁻¹ and an embryo survival price as excessive as 75% after 96 h.⁶⁴

In abstract, these modifications not solely successfully promote drug accumulation at tumor websites and scale back systemic toxicity but in addition considerably improve antitumor efficacy by synergizing a number of therapeutic modalities, thereby enriching the applying prospects of ZIF-8 in biomedicine and different fields.

Cell Membrane Modification

In recent times, cell membrane modification has been extensively utilized in focused tumor remedy, as it will possibly each facilitate immune evasion and actively goal tumors, resulting in accumulation at tumor websites.^65,66 Generally used cell membranes embody most cancers cell membranes, purple blood cell membranes, and macrophage membranes. As a pure barrier, the cell membrane endows nanomedicines with “homologous cell mimicking” properties, granting them the power for “lengthy in vivo circulation,” evading immune recognition, lowering international physique rejection, and concurrently enhancing the structural stability of nanoparticles in vivo.^67,68

Qiao constructed purple blood cell membrane-camouflaged ZIF-8 co-loading DOX and the sort I remodeling progress issue β receptor inhibitor. This considerably enhanced tumor enrichment and deep distribution of DOX, restored ROS manufacturing capability and cytotoxicity of DOX beneath hypoxic situations, and achieved synergistic collagen clearance and hypoxia reduction by modulating the tumor microenvironment, offering a brand new technique for chemotherapy sensitization in stable tumors.⁶⁹ Yang et al used a hybrid membrane composed of Hepa1-6 hepatoma cell membrane and purple blood cell membrane for modification, reaching a twin mechanism of “top-down inhibition of ldl cholesterol synthesis + bottom-up degradation of present ldl cholesterol.” Mixed with sonodynamic remedy (SDT), this strategy achieved a tumor inhibition price of 90% in a liver most cancers mannequin, considerably downregulating the expression of the anti-apoptotic protein Bcl-2 and upregulating the pro-apoptotic protein Bax.⁷⁰

The applying of 4T1 most cancers cell membranes in ZIF-8 primarily exploits their two main biomimetic properties—homologous focusing on and immune evasion—to realize exact remedy for breast most cancers. Zhao constructed ZIF-8 NPs loaded with 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD) and Ce6, coated with 4T1 most cancers cell membranes. The cell membrane synergized with the pH-responsive properties of ZIF-8, reaching launch charges of DMDD and Ce6 of 62.9% and 71.2%, respectively, inside 6 h within the acidic tumor setting. The tumor apoptosis price reached 58.27%, and the tumor inhibition price was considerably increased than that of single therapy teams.⁷¹ Li equally designed 4T1 membrane-coated ZIF-8 NPs loaded with GOx and the autophagy inhibitor chloroquine. Using the synergistic impact of ZIF-8-induced autophagy and its inhibition technique, the nanoparticles had been preferentially taken up by tumor cells. The phagocytosis price by RAW264.7 macrophages was considerably lowered, whereas no vital focusing on was noticed towards heterologous tumor cells akin to HeLa and MCF-7 or regular H9c2 cardiomyocytes, offering a brand new strategy for mixed most cancers hunger remedy and autophagy regulation.⁷²

Macrophage membrane-modified ZIF-8 leverages the inflammatory tropism and immunomodulatory capabilities of macrophages, demonstrating distinctive software benefits in tumor remedy. Zhang constructed copper-doped ZIF-8 NPs coated with genetically engineered M1 macrophage membranes overexpressing CCR2, co-delivering the focused drug β-lapachone and the hypoxia-activated prodrug TH-302. By means of CCR2 binding to CCL2, tumor focusing on was achieved, and pro-tumor macrophage infiltration was lowered. The synergistic ROS burst induced immunogenic cell dying of tumor cells, reversing the immunosuppressive microenvironment induced by incomplete radiofrequency ablation.⁷³ Yang et al expressed HER2 antibodies on macrophage membranes, endowing the nanoparticles with the power to actively acknowledge and bind HER2-overexpressing breast most cancers cells. By means of antibody-dependent cell-mediated cytotoxicity and photothermal results, they reversed the immunosuppressive microenvironment and enhanced antitumor immune responses.⁷⁴

Cell membrane-camouflaged ZIF-8 nanoplatforms, by integrating the drug-loading benefits of metal-organic frameworks with the biomimetic capabilities of pure cell membranes, present a flexible technique for tumor-targeted remedy. As proven in Table 2, researchers have just lately developed varied cell membrane-modified ZIF-8 methods that obtain the combination of immune evasion, homologous focusing on, pH-responsive drug launch, and multimodal synergistic remedy. These biomimetic nanosystems not solely considerably improve drug accumulation and deep penetration at tumor websites but in addition successfully overcome the supply obstacles and drug resistance problems with conventional nanomedicines by modulating the tumor microenvironment.

Desk 2 Functions of Nanocarriers with Completely different Cell Membrane Modifications in Tumor Focused Remedy

A complete comparability of assorted modification methods reveals that PEGylation is probably the most fundamental “invisible” modification, appropriate for almost all ZIF-8 methods, but it surely lacks energetic focusing on functionality; Modifications with small-molecule or polysaccharide ligands, akin to FA and HA, confer energetic focusing on however are restricted by the heterogeneity of goal receptor expression; RGD peptide modification targets the integrin pathway and is flexible throughout varied stable tumors, however multivalent presentation might enhance the danger of immunogenicity; Cell membrane coating represents probably the most biomimetic technique, combining each immune evasion and homologous focusing on capabilities, however the course of is advanced and standardizing membrane sources is troublesome. Researchers ought to rationally choose single or mixed modification methods based mostly on the molecular traits of the goal tumor and medical software situations, quite than blindly stacking practical layers.

Software of ZIF-8 Nanoparticles in Tumor Remedy

Synergistic Chemotherapy

Chemotherapy is likely one of the core modalities of present medical tumor remedy. It includes oral or intravenous administration of chemical medicine that journey by the bloodstream to the complete physique, launching a “non-selective” assault on most cancers cells. The core precept is to intrude with the proliferation of most cancers cells, affecting their DNA, RNA, or protein synthesis, finally resulting in most cancers cell dying.87,88 Nonetheless, the shortage of selectivity typically results in extreme poisonous unwanted side effects, akin to nausea, vomiting, hair loss, and even cardiotoxicity and nephrotoxicity, that are the roots of its disadvantages and unwanted side effects.^89–91 The introduction of the ZIF-8 nanodelivery system affords a brand new strategy to enhancing the therapeutic index of chemotherapeutic medicine. At the moment, chemotherapeutic medicine loaded into ZIF-8 are primarily labeled into three classes: 5-FU, DOX, and PTX, enabling exact pH-responsive launch, focusing on of tumor cells, rising drug loading, and inflicting virtually no injury to regular cells.

Synergistic 5-FU Remedy

5-FU is a first-line drug for treating stable tumors akin to colorectal most cancers, breast most cancers, and head and neck most cancers. ZIF-8 can exactly deal with the shortcomings of 5-FU, together with its quick half-life, excessive toxicity, and poor tumor focusing on.^92,93 Padya et al used ZIF-8 to load 5-FU and coated the floor with SDG. 5-FU disrupts DNA/RNA synthesis to kill tumor cells, whereas SDG blocks the Hedgehog signaling pathway, essentially inhibiting most cancers stem cells and tumor progress. One service concurrently delivers two medicine, overcoming resistance to monotherapy and producing synergistic results whereas inhibiting key signaling pathways and exerting cytotoxic assaults.⁴⁴ Gorish et al built-in machine studying to optimize course of parameters and constructed Lignin@GO@ZIF-8 for the co-delivery of 5-FU and Met for prostate most cancers remedy. This service exhibited low toxicity to regular prostate epithelial cells however demonstrated potent killing results on LNCaP prostate most cancers cells, lowering cell viability to 18 ± 3% at 72 h. The mechanism includes 5-FU inhibiting DNA synthesis, metformin interfering with mobile metabolism, and the service’s personal antitumor results, reaching multi-pathway synergistic most cancers inhibition.⁹⁴ Hao et al discovered that within the 5-FU@ZIF-8 nanodelivery system, the drug loading of 5-FU might attain 271.41 ± 21.94 mg/g. In oral squamous cell carcinoma (OSCC), it exerted antitumor results by downregulating proliferation genes and upregulating apoptosis pathways. ZIF-8 dissolved in acetic acid buffer, and acetic acid, as a lipid synthesis precursor in OSCC, along with tumor microenvironment acidification, constitutes a twin goal for 5-FU focused supply, offering a brand new mechanism for OSCC chemotherapy.⁹⁵ To deal with resistance to single chemotherapeutic medicine, researchers co-encapsulated MTX and 5-FU in ZIF-8 for sequential supply in breast most cancers remedy. The ZIF-8 shell was loaded with MTX, and the mesoporous silica core was loaded with 5-FU. Within the tumor microenvironment, MTX was launched first, adopted by 5-FU, aligning with the synergistic mechanism of “MTX pretreatment enhancing 5-FU goal binding.” In vitro cell experiments confirmed that the IC₅₀ of Fu-MSN@MTX-NMOF towards MCF-7 cells decreased from 51.54 μg/mL to 14.34 μg/mL with rising incubation time (24 h to 72 h), confirming the synergistic impact of sequential launch.⁹⁶

Synergistic DOX Remedy

DOX is a broad-spectrum anticancer drug, however its medical software is restricted by cardiotoxicity, non-specific distribution, and multidrug resistance.^97,98 Research have proven that π-π stacking, hydrogen bonding, and electrostatic interactions exist between DOX and the ZIF-8 framework, which not solely allow environment friendly loading but in addition assist keep the structural integrity of DOX throughout circulation.⁹⁹ Hu et al assembled ZIF-8 with DOX and MnCO into ZIF-8@MnCO@DOX NPs. The mixture of metallic ions and chemotherapy induced a powerful oxidative response by Fenton-like reactions, considerably enhancing the radiation sensitivity of HCC cells and activating the cGAS-STING pathway, thereby catalyzing a potent antitumor immune response (Figure 5).¹⁰⁰ To synchronously ablate tumors with chemotherapy and chemodynamic remedy (CDT), an modern DOX-loaded ZIF-8/SrSe nanozyme was used. The ferroptosis inhibitor Fer-1 partially restored cell viability, and the apoptosis inhibitor ZVAD-FMK additionally partially restored viability, indicating the simultaneous induction of apoptosis and ferroptosis. Annexin V/PI staining confirmed that the ZIF-8/SrSe@DOX group had the best apoptosis price (38.6%), considerably increased than the DOX group (16.7%) and the ZIF-8/SrSe group (35.1%). By pairing DOX with Fenton reactants, GSH was consumed, and ferroptosis and apoptosis had been induced, confirming the feasibility of synergistic apoptosis and ferroptosis induced by chemotherapy and CDT.¹⁰¹ Wu et al first constructed a DOX-Fe₃O₄@ZIF-8 core-shell construction for osteosarcoma remedy, possessing twin benefits of magnetic focusing on and pH-responsive launch. In vivo experiments confirmed that the tumor inhibition price within the DOX-Fe₃O₄@ZIF-8 + magnetic discipline group was as excessive as 83.22%, a lot increased than that of the free DOX group (41.63%) and the Fe₃O₄@ZIF-8 group with no magnetic discipline (61.88%), demonstrating that magnetic focusing on considerably enhanced the chemotherapeutic impact. The toxicity of the Fe₃O₄@ZIF-8 group to the center and liver was considerably decrease than that of the free DOX group, addressing the cardiotoxicity situation in DOX medical software.¹⁰² Wei constructed Cu/ZIF-8@GOx-DOX@HA, during which DOX not solely achieved pH-responsive launch but in addition benefited from H₂O₂ generated by GOx consuming glucose and Cu²⁺-mediated GSH consumption and Fenton reactions, forming a hunger/oxidation/chemotherapy triple synergistic supply system to deal with the inadequate H₂O₂ in CDT.¹⁰³

Synergistic PTX Remedy

Paclitaxel (PTX), the third mostly used chemotherapeutic drug, may also be mixed with the ZIF-8 supply system for exact remedy. PTX was the primary natural-source plant anticancer drug authorized by the US FDA. It promotes tubulin polymerization and inhibits microtubule depolymerization, thereby arresting mitosis on the G2/M section and finally inducing most cancers cell apoptosis.104 Nonetheless, the restricted solubility and excessive toxicity of PTX current challenges and limitations in its software for most cancers remedy.¹⁰⁵ To deal with this situation, Zhao delivered PTX to focus on liver most cancers cells, efficiently reaching managed launch of PTX inside liver most cancers cells. In vitro experiments confirmed that this formulation selectively induced apoptosis in liver most cancers cells, upregulated TNF-α, and induced ROS, whereas exhibiting low toxicity to regular hepatocytes.¹⁰⁶ Geng et al additional studied the co-loading of PTX and propranolol (PRN) in ZIF-8. PTX and Zn²⁺ launched from ZIF-8 induce autophagy (pro-survival impact), whereas PRN, as an autophagy inhibitor, blocks autophagic flux, changing the pro-survival impact of autophagy right into a pro-death impact. Concurrently, this method considerably will increase intracellular ROS ranges, additional inducing apoptosis, representing an modern technique for sensitizing chemotherapy by regulating autophagy.¹⁰⁷ Combining chemotherapy with phototherapy can enormously improve tumor progress inhibition. Lu et al self-assembled ZIF-8 with ICG and Tax into ZIF-8@ICG@Tax. ICG effectively transformed mild power into warmth beneath 808 nm laser irradiation, with a photothermal conversion effectivity of 54.3%. This not solely immediately killed tumor cells by native hyperthermia but in addition considerably enhanced the uptake of nanoparticles by tumor cells, additional amplifying the chemotherapeutic impact. ZIF-8@ICG@Tax mixed with NIR irradiation successfully inhibited tumor progress, elevating the tumor web site temperature to 51.3°C, reaching vital antitumor efficacy whereas lowering the hepatorenal toxicity of Tax by encapsulation.¹⁰⁸

Synergistic Remedy with Different Chemotherapeutic Medication

Along with the three main classes of chemotherapeutic medicine talked about above, ZIF-8 carriers are additionally often mixed with carboplatin (CP), cisplatin (CDDP), and different chemotherapeutic brokers. For CP supply, Ganapathy constructed CP-loaded ZIF-8 nanoparticles for breast most cancers remedy. Cytotoxicity experiments confirmed that the IC₅₀ of CP@ZIF-8 towards MCF-7 breast most cancers cells was 15.01 ± 3.03 µg/mL, considerably higher than that of free CP (34.98 ± 4.25 µg/mL), confirming that ZIF-8 can successfully improve the anti-proliferative exercise and apoptosis-inducing capacity of carboplatin.¹⁰⁹ Dashti et al additional designed ZIF-8-coated chitosan-poly(N-isopropylacrylamide) (CS-PNIPAAm) core-shell nanoparticles for the co-delivery of CP and DOX, exhibiting twin pH/temperature responsiveness and demonstrating vital synergistic killing results in MCF-7 and MDA-MB-231 breast most cancers cells.¹¹⁰ For platinum-resistant ovarian most cancers (PROC), Lin et al developed an epigenetic metal-organic framework nanoagonist (CMZ-Pt-SA@HA) utilizing Mn-ZIF-8 because the core, co-loading CDDP and the histone deacetylase inhibitor SAHA. This method overcomes the triple protection mechanisms of PROC by a number of pathways: SAHA epigenetically downregulates resistance proteins, CaO₂ triggers calcium overload and oxygen launch, and Mn²⁺/Zn²⁺ improve oxidative stress and STING signaling, demonstrating potent therapeutic efficacy in each subcutaneous and patient-derived xenograft fashions.¹¹¹ Zhang et al additionally designed a bimetallic nanoplatform based mostly on ZIF-8 loaded with the cisplatin prodrug Pt(IV). The research discovered that the mechanism of motion of Pt(IV) differs from that of conventional cisplatin; it will possibly bind to the inositol moiety of the mobile messenger IP3, interfering with IP3-mediated cell communication and downregulating cytoplasmic Ca²⁺ focus and downstream signaling, thereby inhibiting tumor cell proliferation and invasion. In the meantime, Zn²⁺ launched from ZIF-8 reduces ATP biosynthesis, additional limiting cell communication, reaching a novel twin mechanism of motion.¹¹²

Synergistic Photothermal Remedy

Photothermal remedy (PTT) makes use of photothermal brokers to soak up NIR radiation and convert it into localized hyperthermia, thereby immediately ablating tumor cells and inducing ICD.¹¹³ The pH responsiveness of ZIF-8, mixed with the photothermal impact generated by NIR irradiation, additional promotes drug launch, reaching a pH/NIR dual-responsive drug supply system that enhances therapy precision and efficacy. The mixed modality displays considerably higher antitumor results than monotherapy.^108,114 Photothermal brokers are labeled into natural and inorganic sorts. Natural supplies have developed quickly in recent times, with their best benefit being good biocompatibility and degradability, lowering the danger of long-term toxicity.¹¹⁵ ICG, as a consultant natural small molecule, is an FDA-approved near-infrared dye for medical use, possessing each photothermal and photodynamic therapeutic results and enabling fluorescence imaging.¹¹⁶ This part focuses on the tumor-killing results of ICG and gold nanomaterials through thermal results.

ICG and DSF had been co-loaded into ZIF-8, and the floor was modified with HA/PEG-grafted-polyglutamic acid (HPG), enhancing the solubility of DSF. In vitro experiments confirmed that ID@ZIF-8@HPG was higher taken up by tumor cells, thereby reaching glorious photothermal and photodynamic properties.¹¹⁷ ICG encapsulated throughout the ZIF-8 framework and modified with CeO₂ nanozymes shaped a bimetallic catalytic system with Zn²⁺ launched from ZIF-8 and Ce³⁺/Ce⁴⁺ from CeO₂. The native hyperthermia (~52.5°C) generated by the photothermal impact of ICG additional accelerated the kinetics of hydroxyl radical era, making a photothermal-enhanced ROS storm that effectively ablated tumors, reaching deep synergy between PTT and CDT. Furthermore, NIR-II imaging guided exact surgical resection of breast most cancers, avoiding residual recurrence.¹¹⁸ As proven in Figure 6, Chen et al launched silk fibroin as a organic template, screened the MCF-7 breast cancer-specific peptide AR, and modified it onto the floor of ZIF-8@ICG/DOX, reaching triple mixture remedy of PTT, PDT, and chemotherapy. Below 808 nm laser irradiation, the native hyperthermia generated by ICG not solely immediately killed tumor cells but in addition promoted the intratumoral penetration of DOX. In vivo experiments demonstrated that AR-ZS/ID-P NPs considerably inhibited tumor progress.¹¹⁹ Integrating radiosensitization and photothermal remedy methods, the environment friendly photothermal conversion of ICG elevated tumor blood provide and oxygenation, overcoming radiotherapy resistance brought on by hypoxia. Feng et al encapsulated rapamycin and ICG in ZIF-8. In vitro experiments proved that RIZM NPs arrested the cell cycle within the G1 section, stopping DNA replication and cell entry into the S section, thereby enhancing radiosensitivity. In vivo efficacy experiments confirmed a radiosensitization enhancement ratio of 1.22 for RIZM NPs, indicating vital radiosensitizing results.¹²⁰

Determine 6 Schematic diagram of AR-ZS/ID-P nanoparticle preparation and focused peptide-guided photothermal and photodynamic remedy for breast most cancers.¹¹⁹ (A–C) The silk fibroin (SF) was ready and added to the 2-HmIm aqueous answer to function a bio-template (A), adopted by the addition of the anticancer drug DOX, the photosensitizer ICG (B), after which the Zn(NO3)₂·6H₂O aqueous answer to type drug-loaded ZIF-8 nanoparticles (termed ZS/ID NPs) by one-pot course of (C). (D) A PEI coating technique was launched to ZS/ID NPs (termed ZS/ID-P NPs) to enhance the soundness of nanoparticles and supply wealthy binding websites for MCF-7 breast tumor-targeting peptides. (E) The MCF-7 breast tumor-targeting peptide AR was linked with ZS/ID-P NPs (termed AR-ZS/ID-P NPs) beneath the motion of EDC/NHS crosslinkers. (F) AR-ZS/ID-P NPs injected into the caudal vein of mice had been guided to tumor by the AR peptide, permitting the NPs to selectively accumulate throughout the tumor. Then, in response to the acidic setting in most cancers cells, AR-ZS/ID-P NPs had been dissolved. Thus, DOX and ICG had been launched from the AR-ZS/ID-P NPs into most cancers cells, resulting in most cancers cell dying with the assistance of a further 808 nm laser. Licensed beneath CC BY.

Inorganic photothermal brokers are based totally on gold-based nanomaterials, which provide excessive photothermal conversion effectivity, steady chemical properties, and ease of floor modification.121,122 To deal with the limitation of PTT-triggered protecting autophagy in tumor cells, FA-modified gold nanoparticles (GNPs) loaded with the autophagy inhibitor bafilomycin had been coated with ZIF-8. The ZIF-8 coating considerably enhanced the soundness of the GNPs with minimal affect on their photothermal efficiency, reaching synergy between autophagy regulation and PTT.¹²³ Huang et al constructed a core-shell construction with a gold nanorod (AuNR) core and a ZIF-8 shell (Au@ZIF-8) loaded with DOX. The Au@ZIF-8 exhibited a photothermal conversion effectivity as excessive as 22%, with concentration- and time-dependent photothermal heating traits. Benefiting from the synergistic impact of PTT and chemotherapy, Au@ZIF-8/DOX effectively gathered on the tumor web site by excessive permeability and the EPR impact. The mixed chemo-photothermal remedy group achieved the perfect tumor inhibition impact, with half of the tumors eradicated and no tumor recurrence, considerably outperforming single-modality therapy teams.¹²⁴ Li et al used ZIF-8 as a service to co-load gold nanorods (GNRs), artesunate, and dequalinium chloride, reaching synergy between PTT and mitochondria-targeted chemotherapy. Artesunate and dequalinium chloride disrupted mitochondrial membrane potential, induced ROS era, and triggered mitochondria-mediated apoptosis. The photothermal impact of GNRs additional amplified this impact, enabling synergistic chemo-photothermal killing and demonstrating glorious in vitro and in vivo therapeutic results towards non-small cell lung most cancers.¹²⁵ Sood et al used ZIF-8 as a sacrificial template to synthesize gold half-shell nanoparticles with robust near-infrared absorption through a one-pot methodology for photothermal ablation of breast most cancers. The photothermal conversion effectivity was roughly 37%, and animal experiments confirmed a disease-free survival price of 75%. Half-shell-mediated photothermal remedy not solely eradicated major tumors but in addition considerably inhibited tumor metastasis to very important organs, enhancing survival charges.¹²⁶

Synergistic Photodynamic Remedy

Photodynamic remedy (PDT) is a minimally invasive, extremely selective tumor therapy modality whose core mechanism depends on three components: a photosensitizer, a particular wavelength of sunshine supply, and molecular oxygen.^127,128 Hypoxia is a standard attribute of stable tumors and a significant factor severely limiting the efficacy of standard PDT.¹²⁹ ZIF-8, by the incorporation of photosensitizers and metallic ions akin to Co²⁺ and Fe²⁺, successfully consumes GSH, amplifies oxidative injury results, catalyzes the manufacturing of extremely poisonous hydroxyl radicals from H₂O₂, and enhances the ROS generated by PDT,^130,131 reaching multimodal synergistic enhancement of PDT with chemodynamic remedy, ion toxicity, and even chemotherapy. This part focuses on the chemical killing of cells by the interplay of photosensitizers and oxygen to provide singlet oxygen and different ROS.

Ce6 and IR780 are two consultant and extensively studied near-infrared photosensitizers. Ce6 focuses on enhancing the effectivity and focusing on of PDT,¹³² whereas IR780 has turn out to be a star molecule for mixed PTT/PDT remedy resulting from its distinctive photophysical properties.¹³³ Ce6 was loaded into ZIF-8, and the outer layer was coated with disulfide bond-containing polydopamine (ssPDA). In a high-GSH tumor setting, the ssPDA layer breaks and consumes GSH, whereas ZIF-8 acid-dissociates to launch Ce6. Below 660 nm laser excitation, Ce6 generates ROS, inducing tumor cell apoptosis, thereby reaching synergy between PDT and ferroptosis (Figure 7).¹³¹ Li co-loaded Ce6 and the chemotherapeutic drug DSF into ZIF-8, together with CuO₂. Upon launch, DSF, Ce6, and Cu²⁺, H₂O₂, O₂ from CuO₂ decomposition had been concurrently launched. DSF chelated with Cu²⁺ to type the CuET advanced, killing most cancers cells by disrupting the ubiquitin-proteasome system and inducing oxidative stress, enhancing DSF chemotherapy. Cu²⁺ catalyzed Fenton-like reactions to realize CDT, whereas O₂ alleviated hypoxia and assisted Ce6 in producing singlet oxygen beneath laser to reinforce PDT, and GSH consumption amplified oxidative stress, reaching triple synergy of chemotherapy, CDT, and PDT.¹³⁴ Yang constructed Ce6-DNAzyme@ZIF-8@PEG nanoparticles, integrating a miR-21 dual-cycle sign amplification imaging system with GPX4-DNAzyme-mediated gene enhancing to reinforce PDT remedy. The loading efficiencies of GPX4-DNAzyme and Ce6 reached 10 wt% and 26 wt%, respectively. By means of Ce6-mediated PDT and GPX4-DNAzyme gene enhancing, the twin mechanism enhanced therapeutic effectivity, reaching extremely delicate miR-21 imaging and PDT remedy for breast most cancers.¹³⁵

Determine 7 Outcomes of Ce6@ZIF-8@ssPDA NPs stimulated ferroptosis activation towards HNCs. (A and B) PCR and Western blot outcomes of GPX4 expression. (C–F) Consultant CLSM photographs and quantitative outcomes of LPO and FerroOrange. (G and H) GSH/GSSG ratio and MDA expression of HN6 cells after therapy of various teams.*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.¹³¹ Licensed beneath CC BY.

IR780 was conjugated with atovaquone (ATO) and co-loaded with DOX into ZIF-8. After launch within the acidic tumor microenvironment, ATO and Zn²⁺ interfered with mitochondrial electron transport and glycolysis, respectively, resulting in power depletion, thereby inhibiting the exercise of P-glycoprotein and HSP70, thus reversing tumor resistance to chemotherapy and PDT.136 IR780 generates ROS for PDT and warmth for PTT upon laser irradiation. In the meantime, GOx catalyzes glucose decomposition, consuming ATP and downregulating the expression of warmth shock protein 90 (HSP90), thereby sensitizing most cancers cells to hyperthermia and considerably enhancing the synergistic therapeutic impact of PDT/PTT.¹³⁷ Gao et al developed a a number of myeloma cell membrane-coated ZIF-8 nanocarrier (D/INPs@CM) co-loading IR780 and DOX. Below NIR laser, the photothermal impact of D/INPs was positively correlated with focus and laser energy. IR-780 supplied the service with environment friendly photothermal conversion and photodynamic exercise. This research achieved, for the primary time, environment friendly accumulation of IR780 in a number of myeloma lesions and synergistic chemo-phototherapy, laying the muse for mixed photo-chemotherapy of different bone marrow-derived hematological tumors.⁸⁶

Along with the above-mentioned star molecules, verteporfin, a benzoporphyrin spinoff, is a photosensitizer that additionally performs an essential function in PDT. When activated by a particular wavelength of sunshine in vivo, it generates ROS, thereby destroying goal tissues.¹³⁸ Yu et al constructed ZIF-8@Ver-M1M nanophotosensitizers. Below laser irradiation, ROS had been successfully generated. Dwell/useless staining confirmed that the proportion of useless cells within the ZIF-8@Ver-M1M group was a lot increased than that within the free verteporfin and uncoated ZIF-8@Ver teams, additional confirming the synergistic PDT killing impact of macrophage membrane modification and laser irradiation.¹³⁹ Moreover, the emergence of recent nanophotosensitizers has injected new vitality into PDT. Cu-Cy NPs are a novel nanophotosensitizer that may be excited by a number of power sources to generate ROS and possess Fenton-like exercise. Li et al utilized Cu-Cy NPs to the therapy of cutaneous squamous cell carcinoma (cSCC). The copper ions triggered Fenton-like reactions and depleted GSH to exert CDT results, whereas beneath UV mild, O₂ was generated to realize PDT results. The synergy between the 2 considerably inhibited cSCC cell proliferation and induced apoptosis, absolutely leveraging the “photosensitizer + enzymatic” twin traits to realize pure synergy between CDT and PDT, overcoming the restrictions of conventional photosensitizer monotherapy.¹⁴⁰

Synergistic Gene Remedy

Gene remedy is a extensively studied different therapy methodology that includes introducing therapeutic genes into most cancers cells or tissues to trigger cell dying or gradual most cancers progress.¹⁴¹ Co-delivery of medicine and genes utilizing nanoparticles can produce synergistic results on tumors and promote mobile uptake by endocytosis.¹⁴² ZIF-8, as a novel non-viral gene vector, affords benefits akin to excessive loading capability, pH responsiveness, and ease of functionalization, offering a brand new strategy for gene remedy.

Li constructed carbon quantum dot (CD)-modified ZIF-8@CDs co-loading DOX and survivin-siRNA. ZIF-8@CDs catalyzed the manufacturing of hydroxyl radicals from H₂O₂ within the tumor microenvironment whereas consuming GSH. The siRNA silenced the anti-apoptotic gene survivin, reversing drug resistance, whereas DOX immediately killed cells. The synergistic impact resulted in an apoptosis price of 49%, reaching vital synergy amongst chemodynamic remedy, chemotherapy, and gene remedy.¹⁴³ An IR780 spinoff (PTA), 2-Hmim, siRNA, and Zn²⁺ self-assembled into siRNA@PT-ZIF-8. The siRNA silenced the warmth shock protein HSP70, enhancing tumor sensitivity to gentle photothermal remedy and considerably enhancing antitumor efficacy, overcoming the restrictions of quick blood circulation half-life and weak stability of free genes, reaching synergistic gene and photothermal remedy.¹⁴⁴ Plasmid DNA containing the p53 tumor suppressor gene was loaded into ZIF-8 to specific regular proteins upon cell entry. ZIF-8-PEI as a p53 gene supply vector exhibited good transfection effectivity and better cell death-inducing capacity in HeLa and MDA-MB-231 cells. The introduction of PEI not solely elevated plasmid loading but in addition enhanced the endosomal escape functionality of the nanoparticles, enhancing gene remedy efficacy.¹⁴⁵ DOX and PD-L1 siRNA had been loaded into ZIF-8 to synthesize RNA-DOX@ZIF-8 (RDZ). RDZ was uniformly blended with catechol-modified chitosan to arrange a multifunctional hydrogel. siPD-L1 silenced PD-L1 in tumors, activating CD8⁺ T cells and releasing granzyme B, thereby activating an antitumor immune response, reaching synergistic native chemotherapy and gene remedy towards tumors.¹⁴⁶ Hu et al co-loaded DOX and MDR1-siRNA into ZIF-8. In vitro experimental outcomes confirmed that the fluorescence depth of DOX within the nucleus was dose- and time-dependent on MDR1 silencing effectivity. siMDR1 effectively silenced MDR1, lowering drug efflux and synergizing with nuclear enrichment, lowering the IC₅₀ by 5.2-fold in contrast with free drug.¹⁴⁷ Saeinasab et al constructed Apt-PEG-siRNA@ZIF-8. SNHG15 is an oncogenic lncRNA extremely expressed in prostate most cancers. Focused supply of SNHG15 siRNA to PC-3 cells extended its systemic circulation time and promoted siRNA launch to silence SNHG15 expression with out affecting its host gene SNORA9, avoiding interference with the host gene.¹⁴⁸

Synergistic Immunotherapy

PD-1/PD-L1 antibodies are generally used immune checkpoint inhibitors that assault tumors by reactivating exhausted T cells and are among the many most generally utilized immunotherapies in medical apply.^149,150 Nonetheless, systemic administration might result in non-specific immune activation, inflicting extreme immune-related antagonistic occasions.¹⁵¹ ZIF-8 carriers have been extensively explored for the focused supply of immunotherapeutic brokers. ZIF-8 can particularly degrade beneath the weakly acidic situations of the tumor microenvironment, reaching managed launch and intratumoral accumulation of PD-1/PD-L1 antibodies or different inhibitors, thereby considerably lowering the immunotoxicity related to systemic publicity whereas enhancing therapeutic efficacy.¹⁵²

As proven in Figure 8, Li et al ready mitoxantrone-loaded ZIF-8 nanoparticles (MIT@ZIF-8). The Zn²⁺-mediated pyroptosis-inducing operate amplified the ICD impact induced by MIT, considerably enhancing calreticulin publicity and HMGB1 launch, thereby activating CD8⁺ cytotoxic T cells and lowering the proportion of regulatory T cells. This transformed immunologically “chilly” prostate most cancers into “sizzling” tumors and considerably sensitized them to anti-CTLA-4 immune checkpoint inhibitors.¹⁵³ ZIF-8 synergized with the DNA methyltransferase inhibitor decitabine (DCT), oxaliplatin (OXA), and imiquimod (R837) to induce pyroptosis in melanoma cells. DCT upregulated the important thing pyroptosis protein GSDME, OXA activated the caspase-3-GSDME pathway to induce tumor cell pyroptosis, and R837, as a TLR7 agonist, amplified the pyroptosis-mediated immunogenic cell dying impact, selling the discharge of damage-associated molecular patterns (DAMPs) akin to ATP, CRT, and HMGB1, activating dendritic cell maturation and CD8⁺ T cell infiltration, reaching native and systemic antitumor immunity.¹⁵⁴ Peng et al used ZIF-8 to load polyphyllin II (PPII), with the floor coated with mesenchymal stem cell membranes for mitochondrial focusing on. Within the tumor microenvironment, PPII was launched, inducing ferroptosis in HCC cells. Mitochondrial stress launched endogenous mtDNA, which particularly activated the cGAS-STING pathway in synergy with Zn²⁺. This drove dendritic cell maturation, polarization of tumor-associated macrophages from M2 to M1, enhanced CD8⁺/CD4⁺ T cell infiltration, and inhibited Tregs, reversing immunosuppression.¹⁵⁵ Lengthy et al reworked ZIF-8 from an inert service right into a multifunctional mitochondrial synchronizer. HA/ZGA co-delivered GOx and 5-ALA, concurrently blocking glucose provide and mitochondrial power metabolism by the triple mechanism of Zn²⁺/GOx/5-ALA, synergistically eliminating most cancers stemness, reversing PD-L1/CD44 co-expression, and triggering cytotoxic T lymphocyte (CTL) infiltration.¹⁵⁶ Yan utilized the Cu²⁺ valence cycle-mediated Fenton-like response and the photosensitizer P18-mediated PDT to generate ROS, additional amplifying pyroptosis and immunogenic cell dying, considerably enhancing antitumor immune responses and inhibiting melanoma progress, offering a brand new strategy for MOF-released Zn²⁺ to manage cell dying pathways and activate antitumor immunity.¹⁵⁷ Liang et al achieved environment friendly encapsulation of the CAR gene in ZIF-8, focused supply to TAMs, and environment friendly intracellular transfection, setting up CAR-macrophages (CAR-M) in situ. Co-delivery of IFN-γ and the CAR gene maintained the precise tumor killing and phagocytic exercise of CAR-M whereas activating adaptive immunity, reaching as much as 95.54% tumor progress inhibition in a prostate most cancers mouse mannequin.¹⁵⁸ αPD-1 antibody-conjugated ZIF-8 nanoparticles launched hyaluronidase and DCT within the acidic TME, degrading the matrix and selling CCL5 secretion, forming a self-reinforcing TIL infiltration cycle. In immunodeficient mice, TIL infiltration elevated 12-fold, reaching tumor eradication and metastasis inhibition in immunocompetent fashions.¹⁵⁹ ZIF-8 co-loaded the chemotherapeutic drug DOX, the indoleamine 2,3-dioxygenase (IDO) inhibitor 1-methyltryptophan (1MT), and the immune adjuvant CpG, reaching synergistic chemotherapy and immunotherapy. In a 4T1 tumor-bearing mannequin, the tumor inhibition price reached 85.6%, with lowered drug toxicity, offering a protected and environment friendly new technique for chemo-immunotherapy.¹⁶⁰ Su et al constructed PDA/(CPT+1-MT)@ZIF-8 (PCMZ) nanoparticles. In vitro and in vivo experiments confirmed that PCMZ NPs successfully inhibited tumor progress, induced ICD in tumor cells, promoted dendritic cell maturation, inhibited the IDO pathway, and finally differentiated T cells into cytotoxic T cells and helper T cells, thereby successfully activating antitumor immune responses.¹⁶¹

Determine 8 (a) Schematic of the design and synthesis of MIT@ZIF-8 nanoparticles for enhanced chemo-immunotherapy. (b) MIT@ZIF-8 successfully amplifies ICD by elevated tumor uptake of MIT and pyroptosis triggered by Zn²⁺ ions, augmenting chemo-immunotherapy for each immunologically “sizzling” and “chilly” cancers and sensitizing prostate most cancers to anti-CTLA-4 immunotherapy.¹⁵³ Licensed beneath CC BY.

As a drug supply service, ZIF-8 displays distinctive benefits together remedy, synergizing with chemotherapy, photodynamic remedy, photothermal remedy, immunotherapy, and gene remedy to realize multimodal mixture antitumor results. To systematically summarize the design methods and key findings of ZIF-8 in numerous synergistic remedy approaches, Table 3 summarizes consultant functions.

Desk 3 Analysis Progress on ZIF-8-Primarily based Nanoparticle Formulations for Synergistic Most cancers Remedy

The pH-responsive properties of ZIF-8 allow a temporal coordination technique of “modifying the microenvironment first, adopted by focused assault”; this differs from conventional mixture therapies the place particular person medicine distribute independently. The coencapsulation technique ensures that totally different therapeutic brokers arrive concurrently on the goal cells, thereby initiating all therapy indicators concurrently and maximizing the synergistic cytotoxic impact. The superior efficacy of multimodal collaborative most cancers remedy in comparison with single-agent therapies may be attributed to its complementary anti-tumor mechanisms, mitigation of the restrictions inherent in monotherapy, reversal of multidrug resistance, discount of off-target systemic toxicity, and transforming of the immunosuppressive tumor microenvironment. The localized hyperthermia generated by photothermal remedy not solely immediately ablates tumors but in addition alleviates hypoxia by enhancing blood perfusion and oxygenation ranges, thereby rising the sensitivity of radiotherapy and photodynamic remedy; conversely, the ROS produced by photodynamic or chemodynamic therapies can eat antioxidant molecules akin to glutathione, additional amplifying the oxidative injury induced by chemotherapeutic brokers, successfully lowering the chance of cross-resistance; moreover, the mixed activation of a number of cell dying pathways—apoptosis, ferroptosis, and pyroptosis can block compensatory survival pathways in tumors, finally overcoming drug resistance.

Challenges and Future Prospects

Regardless of the quite a few breakthrough advances achieved with ZIF-8-based nanodrug supply methods in basic analysis, their translation to medical apply stays fraught with vital challenges. At current, most research are nonetheless confined to mobile and murine fashions, with inadequate proof concerning security profiles and in vivo destiny analysis for medical translation. The cytotoxicity of ZIF-8 is primarily attributed to intracellular accumulation of Zn²⁺ ions, with smaller particles exhibiting increased toxicity, doubtlessly inducing necrotic cell dying through oxidative stress. Moreover, untimely degradation beneath physiological situations might result in untimely drug leakage and even provoke an immunosuppressive microenvironment. Crucial knowledge required by regulatory companies—together with Zn²⁺ metabolic kinetics, degradation product distribution, and continual toxicity—stay largely unavailable.169 When it comes to supply effectivity, the precise efficacy of the traditional EPR impact in human tumors is significantly decrease than that noticed in animal fashions.¹⁷⁰ The excessive interstitial strain, dense extracellular matrix (ECM), and antioxidant methods throughout the tumor microenvironment severely impede deep penetration of nanoparticles and compromise therapeutic efficacy. Thus, designing ZIF-8 nanocarriers able to deep tumor penetration represents a essential path for future analysis. From a producing standpoint, though scale-up processes akin to microfluidics and mechanochemistry have been explored, ton-scale manufacturing compliant with GMP has but to be achieved, and reproducibility, batch-to-batch consistency, and stability stay troublesome to make sure.

To beat these obstacles, future efforts ought to deal with additional enhancing focusing on precision and minimizing off-target results by the design of pH/redox dual-responsive methods, which might facilitate ECM barrier penetration, allow deep tumor supply, and obtain exactly managed Zn²⁺ launch. The adoption of inexperienced and environment friendly manufacturing strategies—akin to microwave-assisted synthesis and mechanochemical approaches—coupled with the institution of standardized GMP-compliant synthesis and characterization protocols, will likely be pivotal for industrial translation. Concurrently, the event of steady formulation methods is important to make sure reliability throughout medical software.

Conclusion

As a nanomaterial, ZIF-8 has demonstrated large potential. It’s not restricted to particular tumor sorts however can function a multifunctional focused service, with extremely tunable optimum functions. Relying on the loaded drug and the conjugated focusing on ligand, this service may be custom-made to match the distinctive traits of assorted malignant tumors. Within the discipline of mixture remedy, the ZIF-8 service has efficiently built-in photothermal remedy, photodynamic remedy, chemodynamic remedy, and chemoradiotherapy right into a single nanocarrier system. Synergistic therapies can concurrently goal totally different websites and pathways; for instance, chemotherapeutic medicine kill quickly proliferating cells, whereas PTT/PDT can ablate drug-resistant “chilly tumor” areas. The 2 approaches complement one another, lowering the chance of recurrence. Multimodal synergistic remedy overcomes the restrictions of monotherapy and, by complementary mechanisms, microenvironment transforming, synchronized drug launch, and systemic immune activation, achieves a qualitative quite than merely quantitative enchancment in therapeutic efficacy; this establishes ZIF-8’s standing as a extremely promising anticancer drug supply platform.

Total, ZIF-8 demonstrates vital technical benefits in enhancing drug focusing on, enhancing therapeutic efficacy, and lowering systemic off-target toxicity. With the continued development of supplies engineering and translational nanomedicine, ZIF-8 holds broad prospects within the discipline of medical translation and is anticipated to evolve right into a common nanoplatform for precision oncology and mixture immunotherapy, finally offering a protected, extremely efficient, and controllable therapeutic device for the therapy of malignant tumors.

Abbreviations

TME, Tumor microenvironment; GSH, Glutathione; MDR, multidrug resistance; NDDS, Nanodrug supply methods; EPR, enhanced permeability and retention; MOFs, Metallic-organic frameworks; ZIF-8, Zeolitic imidazolate framework-8; 2-Meim, 2-methylimidazole; DMF, dimethylformamide; PTT, Photothermal remedy; DOX, doxorubicin; PDI, Polydispersity index; CUR, Curcumin; PDA, Polydopamine; BSA, Bovine serum albumin; TMZ, Temozolomide; TA, Tannic acid; IM, Impregnation methodology; 5-FU, 5-fluorouracil; FR, folate receptor; PEG, Polyethylene glycol; PVP, Polyvinylpyrrolidone; NIR, Close to-infrared; MTX, Methotrexate; FA, Folic acid; GOx, Glucose oxidase; HA, Hyaluronic acid; OSCC, Oral squamous cell carcinoma; DMDD, 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione; CDT, Chemodynamic remedy; PTX, Paclitaxel; PDT, Photodynamic remedy; ICD, Immunogenic cell dying.

Knowledge Sharing Assertion

No new knowledge had been collected, and no new moral approval was required.

Consent for Publication

Knowledgeable consent for publication was obtained from all contributors.

Acknowledgments

Because of all of the authors for his or her assist and contributions to this paper.

Creator Contributions

All authors made a big contribution to the work reported, whether or not that’s within the conception, research design, execution, acquisition of knowledge, evaluation and interpretation, or in all these areas; took half in drafting, revising or critically reviewing the article; gave ultimate approval of the model to be revealed; have agreed on the journal to which the article has been submitted; and conform to be accountable for all elements of the work.

Funding

This research was supported by the Hunan Provincial Pure Science Basis (Grant No.: 2025JJ60912), the Hunan Provincial Division of Schooling Analysis Venture (Grant No.: 24A0277), the Nationwide Undergraduate Innovation and Entrepreneurship Analysis Program (Grant No.: 202210541070), and the Nationwide Key Analysis and Improvement Program (Grant No.: 2022YFD1801101).

Disclosure

The authors declare that they don’t have any competing pursuits.

References

1. Jose J, Kumar R, Harilal S, et al. Magnetic nanoparticles for hyperthermia in most cancers therapy: an rising device. Environ Sci Pollut Res Int. 2020;27(16):19214–28. doi:10.1007/s11356-019-07231-2

2. He S, Xia C, Li H, et al. Most cancers profiles in China and comparisons with the USA: a complete evaluation within the incidence, mortality, survival, staging, and attribution to danger components. Sci China Life Sci. 2024;67(1):122–131. doi:10.1007/s11427-023-2423-1

3. Yin W, Wang J, Jiang L, James Kang Y. Most cancers and stem cells. Exp Biol Med. 2021;246(16):1791–1801. doi:10.1177/15353702211005390

4. Zhou Y, Zhang Y, Gong H, Luo S, Cui Y. The function of exosomes and their functions in most cancers. Int J Mol Sci. 2021;22(22):12204. doi:10.3390/ijms222212204

5. Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of pure energetic components and chemotherapy medicine for most cancers therapy: a evaluate. Drug Deliv. 2022;29(1):2130–2161. doi:10.1080/10717544.2022.2094498

6. Zeng J, Solar Y, Solar S, et al. Leveraging nanodrug supply system for concurrently focusing on tumor cells and M2 tumor-associated macrophages for environment friendly colon most cancers remedy. ACS Appl Mater Interfaces. 2022;14(45):50475–50484. doi:10.1021/acsami.2c11534

7. Chang Y, Cai X, Syahirah R, et al. CAR-neutrophil mediated supply of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nat Commun. 2023;14(1):2266. doi:10.1038/s41467-023-37872-4

8. Wang Y, Li Z, Hu Q. Rising self-regulated micro/nano drug supply gadgets: a step ahead in direction of clever analysis and remedy. Nano At present. 2021;38:101127. doi:10.1016/j.nantod.2021.101127

9. Hoskins BF, Robson R. Infinite polymeric frameworks consisting of three dimensionally linked rod-like segments. J Am Chem Soc. 1989;111(15):5962–5964. doi:10.1021/ja00197a079

10. Shi X, Shan Y, Du M, Pang H. Synthesis and software of metal-organic framework movies. Coord Chem Rev. 2021;444:214060. doi:10.1016/j.ccr.2021.214060

11. Kumar GP, Sanganal JS, Phani AR, et al. Anti-cancerous efficacy and pharmacokinetics of 6-mercaptopurine loaded chitosan nanoparticles. Pharmacol Res. 2015;100:47–57. doi:10.1016/j.phrs.2015.07.025

12. Qin S, Du X, Wang Okay, et al. Vitamin A-modified ZIF-8 lipid nanoparticles for the remedy of liver fibrosis. Int J Pharm. 2023;642:123167. doi:10.1016/j.ijpharm.2023.123167

13. Li S, Juengpanich S, Topatana W, et al. Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder most cancers therapy through artificial lethality. Sci Bull. 2024;69(9):1286–1301. doi:10.1016/j.scib.2024.02.039

14. Shen JJ, Xue SJ, Mei ZH, et al. Synthesis, characterization, and efficacy analysis of a pH-responsive Fe-MOF@GO composite drug supply system for the treating colorectal most cancers. Heliyon. 2024;10(6):e28066. doi:10.1016/j.heliyon.2024.e28066

15. Ren X, Shao M, Li X, et al. Confinement-enhanced electrochemiluminescence by Ru(dcbpy)32+-functionalized γ-CD-MOF@COF-LZU1 porous hybrid materials as micro-reactor for CYFRA 21-1 detection. Talanta. 2024;273:125959. doi:10.1016/j.talanta.2024.125959

16. Ding Y, Xu Y, Yang W, et al. Investigating the EPR impact of nanomedicines in human renal tumors through ex vivo perfusion technique. Nano At present. 2020;35:100970. doi:10.1016/j.nantod.2020.100970

17. Abdelhamid HN. Zeolitic Imidazolate Frameworks (ZIF-8) for biomedical functions: a evaluate. Curr Med Chem. 2021;28(34):7023–7075. doi:10.2174/0929867328666210608143703

18. Zhou J, Liu W, Zhao X, et al. Pure melanin/alginate hydrogels obtain cardiac restore by ROS scavenging and macrophage polarization. Adv Sci. 2021;8(20):e2100505. doi:10.1002/advs.202100505

19. Feng S, Zhang X, Shi D, Wang Z. Zeolitic imidazolate framework-8 (ZIF-8) for drug supply: a essential evaluate. Entrance Chem Sci Eng. 2021;15(2):221–237. doi:10.1007/s11705-020-1927-8

20. Salehipour M, Nikpour S, Rezaei S, et al. Security of metallic–natural framework nanoparticles for biomedical functions: an in vitro toxicity evaluation. Inorg Chem Commun. 2023;152:110655. doi:10.1016/j.inoche.2023.110655

21. Missaoui N, Kahri H, Demirci UB. Fast room-temperature synthesis and characterizations of high-surface-area nanoparticles of zeolitic imidazolate framework-8 (ZIF-8) for CO2 and CH4 adsorption. J Mater Sci. 2022;57(34):16245–16257. doi:10.1007/s10853-022-07676-w

22. Zheng H, Zhang Y, Liu L, et al. One-pot synthesis of metal-organic frameworks with encapsulated goal molecules and their functions for managed drug supply. J Am Chem Soc. 2016;138(3):962–968. doi:10.1021/jacs.5b11720

23. Yang Okay, Cheng S, Li S, Zhu Okay, Yao Z. Exploration of a inexperienced synthesis route of ZIF-8 and testing of its dye adsorption efficiency. J Organomet Chem. 2025;1031:123591. doi:10.1016/j.jorganchem.2025.123591

24. Almutairy B, Alharthi S, Ziora ZM, Ebrahimi Shahmabadi H. Synthesis, radiolabeling, and biodistribution of 99 m-technetium-labeled zif-8 nanoparticles for focused imaging functions. 3 Biotech. 2024;14(12):293. doi:10.1007/s13205-024-04145-w

25. Gao X, Hai X, Baigude H, Guan W, Liu Z. Fabrication of practical hole microspheres constructed from MOF shells: promising drug supply methods with excessive loading capability and focused transport. Sci Rep. 2016;6(1):37705. doi:10.1038/srep37705

26. Bazzi L, Ayouch I, Tachallait H, Hankari SEL. Ultrasound and microwave assisted-synthesis of ZIF-8 from zinc oxide for the adsorption of phosphate. Outcomes Eng. 2022;13:100378. doi:10.1016/j.rineng.2022.100378

27. Yao B, Lua SK, Lim HS, et al. Fast ultrasound-assisted synthesis of controllable Zn/Co-based zeolitic imidazolate framework nanoparticles for heterogeneous catalysis. Microporous Mesoporous Mater. 2021;314:110777. doi:10.1016/j.micromeso.2020.110777

28. Gao Z, Mansor MH, Winder N, et al. Microfluidic-assisted ZIF-Silk-Polydopamine nanoparticles as promising drug carriers for breast most cancers remedy. Pharmaceutics. 2023;15(7):1811. doi:10.3390/pharmaceutics15071811

29. Shen J, Ma M, Shafiq M, Yu H, Lan Z, Chen H. Microfluidics-assisted engineering of pH/Enzyme dual-activatable ZIF@Polymer nanosystem for co-delivery of proteins and chemotherapeutics with enhanced deep-tumor penetration. Angew Chem Int Ed Engl. 2022;61(14):e202113703. doi:10.1002/anie.202113703

30. Carraro F, Williams JD, Linares-Moreau M, et al. Steady-flow synthesis of ZIF-8 biocomposites with tunable particle measurement. Angew Chem. 2020;132(21):8200–8204. doi:10.1002/ange.202000678

31. Taheri M, Bernardo ID, Lowe A, Nisbet DR, Tsuzuki T. Inexperienced full conversion of ZnO nanopowders to well-dispersed Zeolitic Imidazolate Framework-8 (ZIF-8) nanopowders through a stoichiometric mechanochemical response for quick dye adsorption. Cryst Development Des. 2020;20(4):2761–2773. doi:10.1021/acs.cgd.0c00129

32. Tanaka S, Kida Okay, Nagaoka T, Ota T, Miyake Y. Mechanochemical dry conversion of zinc oxide to zeolitic imidazolate framework. Chem Commun. 2013;49(72):7884–7886. doi:10.1039/C3CC43028F

33. Balderas-Xicohtencatl R, Villajos JA, Casabán J, Wong D, Maiwald M, Hirscher M. ZIF-8 pellets as a sturdy materials for hydrogen cryo-adsorption tanks. ACS Appl Power Mater. 2023;6(18):9145–9152. doi:10.1021/acsaem.2c03719

34. Brekalo I, Yuan W, Mottillo C, et al. Manometric real-time research of the mechanochemical synthesis of zeolitic imidazolate frameworks. Chem Sci. 2020;11(8):2141–2147. doi:10.1039/C9SC05514B

35. Wei Y, Chang M, Liu J, Wang N, Wang JX. Spray drying-assisted development of hierarchically porous ZIF-8 for managed launch of doxorubicin. Nanoscale. 2022;14(7):2793–2801. doi:10.1039/d2nr00040g

36. Fan F, Zhao L, Guo Y, Xu H, Wang T, Fu Y. Fabrication of a ZIF-8/PVA membrane on PVDF fiber by spray for the extremely environment friendly separation of oil-in-water emulsions. ACS Appl Mater Interfaces. 2024;16(40):54548–54554. doi:10.1021/acsami.4c10099

37. Arora S, Kumar V, Kapil L, Agrawal AK, Singh A, Singh C. Piperine loaded metallic natural frameworks reverse doxorubicin induced chemobrain in grownup zebrafish. J Management Launch. 2023;355:259–272. doi:10.1016/j.jconrel.2023.01.077

38. Xuan Z, Shen W, Liu H, et al. One-pot inexperienced synthesis of ZIF-8/IgG composite for the exact orientation and safety of antibody and its software in purification and detection of aflatoxins in peanut oil. Meals Chem. 2024;449:139272. doi:10.1016/j.foodchem.2024.139272

39. Zhang X, Chen JY, Pei X, et al. One-pot facile encapsulation of dimethyloxallyl glycine by nanoscale zeolitic imidazolate Frameworks-8 for enhancing vascularized bone regeneration. Adv Healthc Mater. 2023;12(4):e2202317. doi:10.1002/adhm.202202317

40. Guo H, Liu L, Hu Q, Dou H. Monodisperse ZIF-8@dextran nanoparticles co-loaded with hydrophilic and hydrophobic practical cargos for mixed near-infrared fluorescence imaging and photothermal remedy. Acta Biomater. 2022;137:290–304. doi:10.1016/j.actbio.2021.10.006

41. Ren C, Tu Q, He J. Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) improve anticancer exercise and apoptosis induction in glioma most cancers cells. J Biomater Sci Polym Ed. 2024;35(13):1978–1998. doi:10.1080/09205063.2024.2364533

42. Patil RR, Bhagwat DA, Jadhav NR, Nadaf SJ. pH-responsive Zeolitic Imidazolate Framework-8 (ZIF-8) for focused supply of imatinib: enhancing antileukemic efficacy. J Pharm Innov. 2026;21(5):469. doi:10.1007/s12247-026-10673-0

43. Krasnikov АА, Savelyeva ОV, Voronova GA. Energetic ZIF-8-based part (novocaine) supply methods. Basic’nye problemy sovremennogo materialovedenia / Primary Issues of Materials Science. 2023;20(1):23–32. doi:10.25712/ASTU.1811-1416.2023.01.003

44. Padya BS, Fernandes G, Hegde S, et al. Focused supply of 5-Fluorouracil and Sonidegib through surface-modified ZIF-8 MOFs for efficient basal cell carcinoma remedy. Pharmaceutics. 2023;15(11):2594. doi:10.3390/pharmaceutics15112594

45. Mi X, Hu M, Dong M, et al. Folic acid embellished Zeolitic Imidazolate Framework (ZIF-8) loaded with baicalin as a nano-drug supply system for breast most cancers remedy. Int J Nanomed. 2021;16:8337–8352. doi:10.2147/IJN.S340764

46. Liu S, Feng Y. Methods to encapsulate medicine into ZIF-8 and their functions in drug supply. Herald Med. 2022;41(8):1163–1169. doi:10.3870/j.issn.1004-0781.2022.08.015

47. Tsai ST, Tang WC, Wei YK, Wu KCW. Research on Ag(I) loaded ZIF-8 and Ag(I) ion launch in synthetic seawater. Supplies. 2023;16(5):2040. doi:10.3390/ma16052040

48. Peng L, Qiu J, Liu L, Li X, Liu X, Zhang Y. Preparation of PEG/ZIF-8@HF drug supply system for melanoma therapy through oral administration. Drug Deliv. 2022;29(1):1075–1085. doi:10.1080/10717544.2022.2058649

49. Zhang D, Zhang M, Fan H, Solar R, Liu J, Ma W. FA-PEG modified ZIF(Mn) nanoparticles loaded with baicalin for imaging-guided therapy of melanoma in mice. Int J Nanomed. 2024;19:13593–13613. doi:10.2147/IJN.S493185

50. Yuan Y, Li Y, Ji Z, et al. Improved photothermal properties of a functionalized polydopamine mediated by chelating iron ions. Materialia. 2024;34:102063. doi:10.1016/j.mtla.2024.102063

51. Wang L, Zhang L. Analysis progress on the ‘all-in-one’ photothermal platform ready based mostly on polydopamine for tumor synergy remedy. Polym Bull. 2025;82(2):375–395. doi:10.1007/s00289-024-05550-0

52. Zhang X, Han Y, Liu S, et al. MF-094 nanodelivery inhibits oral squamous cell carcinoma by focusing on USP30. Cell Mol Biol Lett. 2022;27(1):107. doi:10.1186/s11658-022-00407-8

53. Yin X, Ran S, Cheng H, et al. Polydopamine-modified ZIF-8 nanoparticles as a drug service for mixed chemo-photothermal osteosarcoma remedy. Colloids Surf B Biointerfaces. 2022;216:112507. doi:10.1016/j.colsurfb.2022.112507

54. Track H, Su C, Cui W, et al. Folic acid-chitosan conjugated nanoparticles for enhancing tumor-targeted drug supply. Biomed Res Int. 2013;2013:723158. doi:10.1155/2013/723158

55. Reshmi R, Jiju KR, Suma S, Anoop SN. Folic acid grafted aminated zeolitic imidazolate framework (ZIF-8) as pH responsive drug service for focused supply of curcumin. J Drug Supply Sci Technol. 2023;79:104098. doi:10.1016/j.jddst.2022.104098

56. Li G, Lu X, Zhang S, et al. Multi-enzyme cascade-triggered nitric oxide launch nanoplatform mixed with chemo starvation-like remedy for multidrug-resistant cancers. ACS Appl Mater Interfaces. 2023;15(26):31285–31299. doi:10.1021/acsami.3c05337

57. Lee SY, Cho HJ. Mitochondria focusing on and destabilizing hyaluronic acid derivative-based nanoparticles for the supply of lapatinib to triple-negative breast most cancers. Biomacromolecules. 2019;20(2):835–845. doi:10.1021/acs.biomac.8b01449

58. Gupta RC, Lall R, Srivastava A, Sinha A. Hyaluronic Acid: molecular Mechanisms and Therapeutic Trajectory. Entrance Vet Sci. 2019;6:192. doi:10.3389/fvets.2019.00192

59. Track Y, Han S, Liu S, Solar R, Zhao L, Yan C. Biodegradable imprinted polymer based mostly on ZIF-8/DOX-HA for synergistically focusing on prostate most cancers cells and managed drug launch with a number of responses. ACS Appl Mater Interfaces. 2023;15(21):25339–25353. doi:10.1021/acsami.3c02647

60. Li Z, Solar L, Lan J, et al. Illuminating the combat towards breast most cancers: preparation and visualized photothermal remedy of hyaluronic acid coated ZIF-8 loading with indocyanine inexperienced and cryptotanshinone for triple-negative breast most cancers. Mater At present Bio. 2024;28:101200. doi:10.1016/j.mtbio.2024.101200

61. Javid H, Oryani MA, Rezagholinejad N, Esparham A, Tajaldini M, Karimi-Shahri M. RGD peptide in most cancers focusing on: advantages, challenges, options, and attainable integrin–RGD interactions. Most cancers Med. 2024;13(2):e6800. doi:10.1002/cam4.6800

62. Yin L, Li X, Wang R, Zeng Y, Zeng Z, Xie T. Current analysis progress of RGD peptide–modified nanodrug supply methods in tumor remedy. Int J Pept Res Ther. 2023;29(4):53. doi:10.1007/s10989-023-10523-4

63. Meng X, Lu Z, Lv Q, Jiang Y, Zhang L, Wang Z. Tumor metabolism destruction through metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced most cancers remedy. Acta Biomater. 2022;145:222–234. doi:10.1016/j.actbio.2022.04.022

64. Kamal NAMA, Abdulmalek E, Fakurazi S, Cordova KE, Abdul Rahman MB. Dissolution and organic evaluation of cancer-targeting Nano-ZIF-8 in Zebrafish Embryos. ACS Biomater Sci Eng. 2022;8(6):2445–2454. doi:10.1021/acsbiomaterials.2c00186

65. Liu C, Gao J, Cheng Y, Zhang S, Fu C. Homologous-adhering/focusing on cell membrane- and cell-mediated supply methods: a cancer-catch-cancer technique in most cancers remedy. Regen Biomater. 2025;12:rbae135. doi:10.1093/rb/rbae135

66. Ma Y, Jiang Q, Liu X, Solar X, Liang G. In situ peptide meeting for cell membrane rewiring in tumor remedy. J Management Launch. 2025;381:113637. doi:10.1016/j.jconrel.2025.113637

67. Du Y, Deng T, Cheng Y, et al. Enhancing bone regeneration by CDC20-Loaded ZIF-8 nanoparticles wrapped in erythrocyte membranes with focusing on aptamer. Adv Healthc Mater. 2024;13(7):e2302725. doi:10.1002/adhm.202302725

68. Duan H, Wang L, Wang S, He Y. Floor modification potentials of cell membrane-based supplies for focused therapies: a chemotherapy-focused evaluate. Nanomedicine. 2023;18(19):1281–1303. doi:10.2217/nnm-2023-0164

69. Qiao C, Wang X, Liu G, et al. Erythrocyte membrane camouflaged metallic–natural framework nanodrugs for reworked tumor microenvironment and enhanced tumor chemotherapy. Adv Funct Mater. 2022;32(6):2107791. doi:10.1002/adfm.202107791

70. Yang M, Chen W, Zhou J, Guan F, Jin R. “Prime-down and Backside-up” cholesterol-depleting biomimetic nanoparticle for enhancing sonodynamic remedy towards hepatocellular carcinoma. Mater At present Bio. 2025;35:102370. doi:10.1016/j.mtbio.2025.102370

71. Zhao S, Chen M, Yu Z, et al. Biomimetic cytomembrane-coated ZIF-8-loaded DMDD nanoparticle and sonodynamic co-therapy for most cancers. Ann Transl Med. 2022;10(18):971. doi:10.21037/atm-22-3646

72. Li F, Chen T, Wang F, et al. Enhanced most cancers hunger remedy enabled by an autophagy inhibitors-encapsulated biomimetic ZIF-8 nanodrug: disrupting and harnessing twin pro-survival autophagic responses. ACS Appl Mater Interfaces. 2022;14(19):21860–21871. doi:10.1021/acsami.2c00552

73. Zhang WH, Chen L, Gao L, et al. Engineered macrophage membrane-mimicking nanodrugs activate cGAS/STING pathway to reverse tumor immune suppression after incomplete radiofrequency ablation. J Nanobiotechnology. 2025;24(1):55. doi:10.1186/s12951-025-03889-8

74. Yang P, Du F, Zhang W, et al. Ingenious designed a HER2-Particular macrophage biomimetic multifunctional nanoplatform for enhanced bio-photothermal synergistic remedy in HER2 constructive breast most cancers. Mater At present Bio. 2024;26:101095. doi:10.1016/j.mtbio.2024.101095

75. Han X, Zhou C, Luo X, et al. Tumor focusing on with apatinib-loaded nanoparticles and sonodynamic mixed remedy. Curr Mol Med. 2024;24(5):648–666. doi:10.2174/1566524023666230613140341

76. Wei X, Huang H, Guo J, et al. Biomimetic nano-immunoactivator through ionic metabolic modulation for strengthened NIR-II photothermal immunotherapy. Small. 2023;19(49):e2304370. doi:10.1002/smll.202304370

77. Feng Y, Track W, Lin Z, et al. PET imaging-guided biomimetic nanoplatform reprograms the tumor immune microenvironment and disrupts stromal obstacles to potentiate immunotherapy in malignancy. Chem Eng J. 2026;527:171777. doi:10.1016/j.cej.2025.171777

78. Solar X, He G, Xiong C, et al. One-pot fabrication of hole porphyrinic MOF nanoparticles with ultrahigh drug loading towards managed supply and synergistic most cancers remedy. ACS Appl Mater Interfaces. 2021;13(3):3679–3693. doi:10.1021/acsami.0c20617

79. Yan J, Ji S, Chang T, et al. Building of bionic nanoparticles camouflaged with macrophage membranes for drug supply in breast most cancers. J Drug Supply Sci Technol. 2023;84:104433. doi:10.1016/j.jddst.2023.104433

80. Ni W, Zhang M, Mo Y, et al. Macrophage membrane-based biomimetic nanocarrier system for enhanced immune activation and mixture remedy in liver most cancers. Drug Deliv Transl Res. 2025;15(5):1540–1553. doi:10.1007/s13346-024-01690-y

81. Ling Okay, Zhao Z, Wu R, et al. Macrophage-membrane-coated hybrid nanoparticles with self-supplied hydrogen peroxide for enhanced chemodynamic tumor remedy. Nanoscale. 2024;16(4):1673–1684. doi:10.1039/d3nr03989g

82. Ren L, Solar Y, Zhang J, et al. Crimson blood cell membrane-coated functionalized Cu-doped metallic natural framework nanoformulations as a biomimetic platform for improved chemo-/chemodynamic/photothermal synergistic remedy. Int J Pharm. 2024;652:123811. doi:10.1016/j.ijpharm.2024.123811

83. Zhao Z, Liu Z, Hua Y, et al. Biomimetic ZIF8 nanosystem with tumor hypoxia reduction capacity to reinforce chemo-photothermal synergistic remedy. Entrance Pharmacol. 2022;13:850534. doi:10.3389/fphar.2022.850534

84. Cling L, Zhang T, Wen H, et al. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic remedy and tumor metastasis suppression. Theranostics. 2021;11(20):10001–10011. doi:10.7150/thno.65399

85. Yuan P, Zhu T, Yan X, et al. Vascular-targeted nanoplatform for enhanced immunotherapy through synergistic thrombosis and hypoxia-activated chemotherapy. ACS Appl Mater Interfaces. 2025;17(23):33528–33539. doi:10.1021/acsami.5c04442

86. Gao G, Che J, Xu P, Chen B, Zhao Y. Biomimetic cell membrane embellished ZIF-8 nanocarriers with IR-780 and doxorubicin loading for a number of myeloma therapy. Combination. 2024;5(6):e631. doi:10.1002/agt2.631

87. Amjad MT, Chidharla A, Kasi A. Most cancers chemotherapy. In: StatPearls. StatPearls Publishing; 2023.

88. Tilsed CM, Fisher SA, Nowak AK, Lake RA, Lesterhuis WJ. Most cancers chemotherapy: insights into mobile and tumor microenvironmental mechanisms of motion. Entrance Oncol. 2022;12:960317. doi:10.3389/fonc.2022.960317

89. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Most cancers drug resistance: an evolving paradigm. Nat Rev Most cancers. 2013;13(10):714–726. doi:10.1038/nrc3599

90. Bostick BB. Issues of Chemotherapy. Emerg Med Clin North Am. 2025;43(3):475–487. doi:10.1016/j.emc.2025.03.009

91. Spreafico F, Gattuso G, Podda MG, et al. Lengthy-term antagonistic results of contemporary Wilms tumour therapies: implications for monitoring. Nat Rev Urol. 2026:1–16. doi:10.1038/s41585-026-01126-x

92. Solar CY, Qin C, Wang XL, et al. Zeolitic Imidazolate framework-8 as environment friendly pH-sensitive drug supply automobile. Dalton Trans. 2012;41(23):6906–6909. doi:10.1039/c2dt30357d

93. Ilhan Y, Balcık OY, Sahın E, et al. Efficacy and security of omitting 5-fluorouracil bolus together chemotherapy regimens for gastrointestinal cancers: a scientific evaluate and meta-analysis. Knowledgeable Opin Drug Saf. 2025:1–10. doi:10.1080/14740338.2025.2527962

94. Gorish BMT, Abdelmula WIY, Wenqian D, Yue B, Yahu L, Zhu D. AI-guided design of pH- and redox-responsive Lignin@GO@ZIF-8 nanocarriers for focused co-delivery of 5-fluorouracil and metformin in prostate most cancers remedy. Small. 2026;e13085. doi:10.1002/smll.202513085

95. Hao J, Chen C, Pavelic Okay, Ozer F. ZIF-8 as a pH-responsive nanoplatform for 5-fluorouracil supply within the chemotherapy of oral squamous cell carcinoma. Int J Mol Sci. 2024;25(17):9292. doi:10.3390/ijms25179292

96. Mansour A, Fytory M, Ahmed OM, Rahman FEZSA, El-Sherbiny IM. In-vitro and in-vivo evaluation of pH-responsive core-shell nanocarrier system for sequential supply of methotrexate and 5-fluorouracil for the therapy of breast most cancers. Int J Pharm. 2023;648:123608. doi:10.1016/j.ijpharm.2023.123608

97. Mete D, Şanlı-mohamed G. Structural and practical tuning of ZIF-8 nanoparticles through zinc salt variation and ligand ratio for enhanced drug supply. J Nanopart Res. 2025;27(9):240. doi:10.1007/s11051-025-06424-w

98. Hulsurkar MM, Wehrens XHT. Doxorubicin-induced cardiotoxicity: can andrographolide present a silver lining? Cardiovasc Medication Ther. 2025;39(5):935–939. doi:10.1007/s10557-025-07674-5

99. Tran VA, Lee SW. pH-triggered degradation and launch of doxorubicin from zeolitic imidazolate framework-8 (ZIF8) embellished with polyacrylic acid. RSC Adv. 2021;11(16):9222–9234. doi:10.1039/d0ra10423j

100. Hu X, Zhu H, Shen Y, et al. Metallic-organic framework nanoparticles activate cGAS-STING pathway to enhance radiotherapy sensitivity. J Nanobiotechnology. 2025;23(1):131. doi:10.1186/s12951-025-03229-w

101. Wu A, Han M, Ni Z, et al. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor remedy through apoptosis and ferroptosis. Theranostics. 2024;14(5):1939–1955. doi:10.7150/thno.92663

102. Wu W, Yu X, Solar J, et al. Zeolitic Imidazolate Framework (ZIF-8) embellished iron oxide nanoparticles loaded doxorubicin hydrochloride for osteosarcoma therapy – in vitro and in vivo preclinical research. Int J Nanomed. 2023;18:7985–7999. doi:10.2147/IJN.S438771

103. Wei F, Hou L, Yao Y, et al. An clever Cu/ZIF-8-based nanodrug supply system for tumor-specific and synergistic remedy through tumor microenvironment-responsive cascade response. Mikrochim Acta. 2024;191(8):447. doi:10.1007/s00604-024-06527-6

104. Qi Q, Zhang Z, Wang D. GSH-responsive paclitaxel prodrug utilized in chemotherapy together with photodynamic remedy. Bioorg Chem. 2025;157:108289. doi:10.1016/j.bioorg.2025.108289

105. Abbaspour S, Mohamadzadeh M, Shojaosadati SA. Protein-based nanocarriers for paclitaxel (PTX) supply in most cancers therapy: a evaluate. Int J Biol Macromol. 2025;310(Pt 1):143068. doi:10.1016/j.ijbiomac.2025.143068

106. Zhao X, Wu X, Ruan L, et al. Synergistic supply of paclitaxel-coated ZIF-8 metal-organic framework nanoparticles for enhanced in vitro administration in liver most cancers cell traces. J Clust Sci. 2025;36(2):45. doi:10.1007/s10876-024-02739-1

107. Geng Y, Huang S, Ma L, et al. Propranolol-induced autophagic dysfunction mixed with a focused metal-organic framework as a novel technique for enhancing antitumor therapeutic efficacy. Appl Mater At present. 2023;33:101886. doi:10.1016/j.apmt.2023.101886

108. Lu Okay, Pan X, Zheng J, Cheng D, Zheng L, Zhang X. Theranostic nanoparticles ZIF-8@ICG for pH/NIR-responsive drug-release and NIR-guided chemo-phototherapy towards non-small-cell lung most cancers. J Mater Sci Mater Med. 2024;35(1):32. doi:10.1007/s10856-024-06802-1

109. Ganapathy S, Bharathi M, Hirad AH, et al. Carboplatin-loaded zeolitic imidazolate framework-8: induction of antiproliferative exercise and apoptosis in breast most cancers cell. Biotechnol Appl Biochem. 2025;72(3):683–694. doi:10.1002/bab.2689

110. Dashti N, Akbari V, Varshosaz J, Soleimanbeigi M, Rostami M. Co-delivery of carboplatin and doxorubicin utilizing ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles by a twin pH/thermo responsive technique to breast most cancers cells. Int J Biol Macromol. 2024;269(Pt 1):131971. doi:10.1016/j.ijbiomac.2024.131971

111. Lin L, Zhang Q, Liu X, et al. Epigenetic metal-organic framework nanoagonist overcomes triple defenses to allow efficient chemo-metalloimmunotherapy in platinum-resistant ovarian most cancers. Adv Mater. 2026:e17286. doi:10.1002/adma.202517286

112. Zhang S, Ji X, Liu Z, et al. Bimetallic nanoplatforms for prostate most cancers therapy by interfering mobile communication. J Am Chem Soc. 2024;146(32):22530–22540. doi:10.1021/jacs.4c06267

113. ChenLiu Z, Gu C, Wang L, Wu Q, Tang D. Nanocarrier-mediated photothermal remedy and its mixed methods: mechanism exploration and software in tumour therapy. Most cancers Nano. 2025;16(1):47. doi:10.1186/s12645-025-00349-8

114. Yang T, Wang T, Shen T, et al. Tumor microenvironment-responsive nanoplatform of Cu-Doped ZIF-8 dual-loaded with ICG and DOX for photothermal-enhanced chemodynamic remedy/chemotherapy. ACS Omega. 2026;11(7):12148–12162. doi:10.1021/acsomega.5c11491

115. Han X, Feng G, Li X, et al. Purposeful nanomaterials for enhanced tumor photothermal remedy – the mechanisms and functions. Entrance Pharmacol. 2025;16:1604965. doi:10.3389/fphar.2025.1604965

116. Li J, Tian S, Zhang X, Deng X, Xu H, Yan L. Indocyanine green-based nanomedicine for theranostic functions. Biomater Sci. 2025;13(16):4321–4357. doi:10.1039/d5bm00670h

117. Zeng C, Jiang X, Ji M, et al. pH-responsive ZIF-8 nanoplatform co-loaded with DSF and ICG for a number of synergistic antitumor remedy. Int J Pharm. 2025;672:125343. doi:10.1016/j.ijpharm.2025.125343

118. Li T, Lin L, Li X, et al. Tumor microenvironment-responsive cerium oxide nanozyme coated ZIF-8 nanoplatform with ICG encapsulation for exact breast most cancers surgical procedure and efficacious synergistic suppression. Mater At present Bio. 2025;35:102568. doi:10.1016/j.mtbio.2025.102568

119. Chen Y, Lyu R, Wang J, et al. Metallic-organic frameworks nucleated by silk fibroin and modified with tumor-targeting peptides for focused multimodal most cancers remedy. Adv Sci. 2023;10(28):e2302700. doi:10.1002/advs.202302700

120. Feng Y, Li Z, Track L, et al. A ZIF-8-based dual-modal good responsive nanoplatform for overcoming radiotherapy resistance in superior tumors. Nanoscale. 2025;17(19):12134–12148. doi:10.1039/d5nr01093d

121. Jiao Y, Zhang Y, Dong C, et al. Current advances in inorganic nanocomposites for the photothermal remedy of bone tumors. Nanoscale Horiz. 2026;11(3):719–738. doi:10.1039/D5NH00692A

122. Zhu H, Li B, Yu Chan C, et al. Advances in Single-component inorganic nanostructures for photoacoustic imaging guided photothermal remedy. Adv Drug Deliv Rev. 2023;192:114644. doi:10.1016/j.addr.2022.114644

123. Xu Y, Ling P, Huang N, Ma X. Fabrication of folate-decorated bafilomycin-loaded gold-coated MOF inhibits autophagy in cervical most cancers cells for enhancing photothermal remedy. J Nanopart Res. 2026;28(2):29. doi:10.1007/s11051-026-06547-8

124. Huang J, Xu Z, Jiang Y, et al. Metallic natural framework-coated gold nanorod as an on-demand drug supply platform for chemo-photothermal most cancers remedy. J Nanobiotechnology. 2021;19(1):219. doi:10.1186/s12951-021-00961-x

125. Li X, Wang J, Li W, et al. Mixed photothermal/mixture chemotherapeutic strategy utilizing Zif-8-supported artesunate and gold nanorods. ACS Appl Nano Mater. 2024;7(10):11587–11598. doi:10.1021/acsanm.4c01102

126. Sood Okay, Mathur P, Rath S, et al. Plasmonic semi shells derived from simultaneous in situ gold progress and anisotropic acid etching of ZIF-8 for photothermal ablation of metastatic breast tumor. Commun Chem. 2024;7(1):231. doi:10.1038/s42004-024-01317-w

127. Nizami NA, Rafiya Okay, Hasan N, Ahmad FJ. Photonanomedicine for Most cancers: a nanotechnology-based development in photodynamic remedy. Int J Pharm. 2025;686:126346. doi:10.1016/j.ijpharm.2025.126346

128. Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic remedy – mechanisms, photosensitizers and mixtures. Biomed Pharmacother. 2018;106:1098–1107. doi:10.1016/j.biopha.2018.07.049

129. Zhang L, Fan Y, Yang Z, Yang M, Wong CY. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for mixed most cancers remedy. J Nanobiotechnol. 2021;19(1):265. doi:10.1186/s12951-021-01003-2

130. Jiang F, Zhao Y, Yang C, et al. A tumor microenvironment-responsive Co/ZIF-8/ICG/Pt nanoplatform for chemodynamic and enhanced photodynamic antitumor remedy. Dalton Trans. 2022;51(7):2798–2804. doi:10.1039/d1dt04120g

131. Wang M, Li F, Lu T, Wu R, Yang S, Chen W. Photodynamic and ferroptotic Ce6@ZIF-8@ssPDA for head and neck most cancers therapy. Mater Des. 2022;224:111403. doi:10.1016/j.matdes.2022.111403

132. Li Y, Giang Phan VH, Pan Z, et al. Built-in and hyaluronic acid-coated mesoporous silica nanoparticles conjugated with cisplatin and chlorin e6 for mixed chemo and photodynamic most cancers remedy. Eur Polym J. 2024;220:113426. doi:10.1016/j.eurpolymj.2024.113426

133. Tsai MC, Hsiao LY, Chang YH, et al. Enhanced intracellular IR780 supply by acidity-triggered PEG-detachable hybrid nanoparticles to reinforce photodynamic and photothermal mixture remedy for melanoma therapy. ACS Appl Bio Mater. 2025;8(5):3995–4007. doi:10.1021/acsabm.5c00144

134. Li T, Rong M, Wang Y, Solar W, Lu L. A cascade nanoplatform for clever response to tumor microenvironment and collaborative most cancers remedy. J Mater Chem B. 2024;12(10):2537–2546. doi:10.1039/d3tb02879h

135. Yang Z, Qin R, Ruan D, et al. Ce6-DNAzyme-loaded metal-organic framework theranostic brokers for enhancing miRNA imaging-guided photodynamic remedy in breast most cancers. ACS Nano. 2025;19(30):27873–27889. doi:10.1021/acsnano.5c09287

136. Lu S, Tian H, Li L, et al. Nanoengineering a Zeolitic Imidazolate Framework-8 able to manipulating power metabolism towards most cancers chemo-phototherapy resistance. Small. 2022;18(48):e2204926. doi:10.1002/smll.202204926

137. Qi G, Chen Okay, Guan W, et al. One-Pot Synthesis of a pH-Delicate MOF built-in with glucose oxidase for amplified tumor photodynamic/photothermal remedy. ACS Appl Mater Interfaces. 2024;16(37):49083–49091. doi:10.1021/acsami.4c10006

138. Carigga Gutierrez NM, Backyard L, Le Clainche T, et al. Photochemical internalization with verteporfin-liposomes enhances oxaliplatin retention and efficacy in fashions of pancreatic most cancers. J Management Launch. 2025;387:114201. doi:10.1016/j.jconrel.2025.114201

139. Yu L, Zhu G, Zhang Z, et al. Nano-photosensitizer directed focused phototherapy efficient towards oral most cancers in animal mannequin. Int J Nanomed. 2023;18:6185–6198. doi:10.2147/IJN.S434917

140. Li N, Wan X, Hou X, et al. Cu-Cy Nps@ZIF-8@HA-mediated photodynamic remedy for cutaneous squamous cell carcinoma. IJN. 2026;21:1–16. doi:10.2147/IJN.S560049

141. Cesur-Ergün B, Demir-Dora D. Gene remedy in most cancers. J Gene Med. 2023;25(11):e3550. doi:10.1002/jgm.3550

142. Ashrafizadeh M, Zarrabi A, Bigham A, et al. (Nano)platforms in breast most cancers remedy: drug/gene supply, superior nanocarriers and immunotherapy. Med Res Rev. 2023;43(6). doi:10.1002/med.21971

143. Li Y, Pan J, Xu L, Solar Y, Li T. Fluorescent nanoporous gene medicine with fenton-like catalysis vector analysis. Nanomaterials. 2026;16(2):120. doi:10.3390/nano16020120

144. Hu H, Yang N, Solar J, et al. Zn(ii)-Coordination-driven self-assembled nanoagents for multimodal imaging-guided photothermal/gene synergistic remedy. Chem Sci. 2022;13(24):7355–7364. doi:10.1039/d2sc01769e

145. Salari R, Rastegari B, Hashemi A, Farjadfar A, Masoomi MY. P53 gene remedy with ZIF-8 metal-organic framework: a platform in most cancers gene remedy. ACS Omega. 2025;10(11):10891–10902. doi:10.1021/acsomega.4c08739

146. Zhou J, Lin G, Fu X, et al. ZIF-8-modified multifunctional hydrogel loading siRNA and DOX for postoperative remedy of maxillofacial osteosarcoma and bone restore. ACS Appl Mater Interfaces. 2025;17(12):17990–18002. doi:10.1021/acsami.4c21331

147. Hu J, Wang J, Zhuang J, et al. Enhanced nuclear enrichment of chemotherapeutics by a biomimetic ZIF-8 nanosystem for multidrug-resistant most cancers therapy. Eur J Pharm Sci. 2026;217:107396. doi:10.1016/j.ejps.2025.107396

148. Saeinasab M, Iranpour S, Hosseini-Giv N, Saljooghi AS, Matin MM. Tumor-targeted supply of SNHG15 siRNA utilizing a ZIF-8 nanoplatform: in direction of a more practical prostate most cancers remedy. Int J Biol Macromol. 2024;259(Pt 1):129233. doi:10.1016/j.ijbiomac.2024.129233

149. Li J, Zeng H, Li L, Yang Q, He L, Dong M. Superior era therapeutics: biomimetic nanodelivery system for tumor immunotherapy. ACS Nano. 2023;17(24):24593–24618. doi:10.1021/acsnano.3c10212

150. Singh D, Bedi N. Nano-immunoconjugates in immune checkpoint blockade: a twin strategy to precision immunotherapy and real-time imaging. Asia Pac J Clin Oncol. 2026;22(3):369–380. doi:10.1111/ajco.70036

151. Parveen S, Konde DV, Paikray SK, et al. Nanoimmunotherapy: the good trooper for most cancers remedy. Explor Goal Antitumor Ther. 2025;6:1002308. doi:10.37349/etat.2025.1002308

152. Gong L, Liu Y, Feng J, et al. An immune activator encapsulating PD-L1 siRNA for augmented immune checkpoint blockade immunotherapy by Zn2+ overload triggered pyroptosis. J Nanobiotechnology. 2025;23(1):447. doi:10.1186/s12951-025-03521-9

153. Li J, Lv W, Han Z, et al. Mitoxantrone-encapsulated ZIF-8 enhances chemo-immunotherapy through amplified immunogenic cell dying. Adv Sci. 2025;12(14):e2501542. doi:10.1002/advs.202501542

154. Solar S, He Y, Xu J, et al. Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy. J Management Launch. 2024;367:470–485. doi:10.1016/j.jconrel.2024.01.057

155. Peng H, Chang A, Zhang H, et al. A novel biomimetic nanoplatform amplifies ferroptosis for particular cGAS-STING pathway activation to reinforce hepatocellular carcinoma chemo-immunotherapy. J Nanobiotechnol. 2025;23(1):799. doi:10.1186/s12951-025-03870-5

156. Lengthy Y, Cheng W, Tian H, et al. Zinc-coordination-driven mitochondrial nanodisruptors to ablate most cancers stemness for potentiating immunotherapy in colorectal malignancies. J Nanobiotechnol. 2026. doi:10.1186/s12951-026-04184-w

157. Yan X, Chen C, Ren Y, et al. A dual-pathway pyroptosis inducer based mostly on Au-Cu2-xSe@ZIF-8 enhances tumor immunotherapy by disrupting the zinc ion homeostasis. Acta Biomater. 2024;188:329–343. doi:10.1016/j.actbio.2024.09.015

158. Liang Z, Wang R, Wang Y, et al. Hierarchical zeolitic imidazolate Framework-8@Au cluster nanocarriers for in situ chimeric antigen receptor macrophage programming and immunotherapy in prostate most cancers. ACS Nano. 2026. doi:10.1021/acsnano.5c11870

159. Gan Z, Huang J, Duan S, et al. αPD-1-conjugated acid-cleavable nanodrugs overcomes mobile immunotherapy obstacles in pancreatic tumors. Nat Commun. 2025;17(1):562. doi:10.1038/s41467-025-67254-x

160. Qi H, Geng Y, Li Y, Wu Y, Cai X. The hybrid nano-platform based mostly on ZIF-8 realises the synergistic remedy of tumour chemo-immunotherapy. J Drug Goal. 2025;33(9):1656–1670. doi:10.1080/1061186X.2025.2519602

161. Su R, Yang Y, Wu H, et al. Synergistic photothermal tumor immunotherapy by 1-MT based mostly on zeolitic imidazolate Framework-8 with pH-high sensitivity. Int J Nanomed. 2024;19:8501–8517. doi:10.2147/IJN.S449820

162. Li X, Zhou Q, Duan S, et al. An active-targeted ZIF8-based nanotheranostic platform for ultrasound imaging-guided synergistic remedy of triple-negative breast most cancers. Ijn. 2026;21:1–22. doi:10.2147/IJN.S589815

163. Yu Z, Cao W, Han C, et al. Biomimetic metal-organic framework nanoparticles for synergistic combining of SDT-chemotherapy induce pyroptosis in gastric most cancers. Entrance Bioeng Biotechnol. 2022;10:796820. doi:10.3389/fbioe.2022.796820

164. Zhou S, Shang Q, Ji J, Luan Y. A nanoplatform to amplify apoptosis-to-pyroptosis immunotherapy through immunomodulation of myeloid-derived suppressor cells. ACS Appl Mater Interfaces. 2021;13(40):47407–47417. doi:10.1021/acsami.1c16154

165. Qin S, Zhao HY, Luo XY, et al. Photothermally bolstered nanozyme transforming tumor microenvironment of redox and metabolic homeostasis to reinforce ferroptosis in tumor remedy. ACS Nano. 2024;18(46):32235–32254. doi:10.1021/acsnano.4c13087

166. Chen MM, Hao HL, Zhao W, Zhao X, Chen HY, Xu JJ. A plasmon-enhanced theranostic nanoplatform for synergistic chemo-phototherapy of hypoxic tumors within the NIR-II window. Chem Sci. 2021;12(32):10848–10854. doi:10.1039/D1SC01760H

167. Qiao Y, Luo M, Wang Y, et al. Improvement of a bacteria-nanosapper for the energetic supply of ZIF-8 particles containing therapeutic genes for most cancers immune remedy. Acta Pharmaceutica Sinica B. 2024;14(12):5418–5434. doi:10.1016/j.apsb.2024.07.020

168. Jiahui Okay, Yongqiang Z, Yuchang Y, et al. Biomimetic MOFs nanoparticles Co-delivering oridonin and siRNA for synergistic remedy in melanoma through ferroptosis pathway. J Sci. 2025;10(3):100957. doi:10.1016/j.jsamd.2025.100957

169. Jing X, Ma Y, Liu Y, Yin X. Security, in vivo destiny, and degradation of MOF nanomedicines: towards translational analysis. Pharmaceutics. 2026;18(5):548. doi:10.3390/pharmaceutics18050548

170. Tong P, Wang R, Zhou Y, et al. Enhancing the focusing on capacity of metal-organic frameworks in most cancers remedy and analysis. Nat Rev Chem. 2026;10(4):258–276. doi:10.1038/s41570-026-00807-w

Source link